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Abstract 
Aleutian mink disease virus (AMDV) is a widespread parvovirus mainly affecting 
American mink (Neovison vison). It can cause a progressive and persistent immune 
complex-mediated disease (Aleutian disease, AD) in adult mink and an acute and fatal 
pneumonia in mink kits. The virus has a wide geographical distribution both in farmed 
mink and in the wild. Aleutian mink disease virus poses a major economic threat to mink 
farmers and it may affect the conservation and management of indigenous mustelids and 
other species. Infected farms are difficult to sanitize as the virus is resistant to physical and 
chemical treatments, it can be transmitted through several vectors and routes, and no 
effective medications or vaccines currently exist. Since the 1970s, diagnosis on AMDV in 
farmed mink has been based on the identification of specific antibodies with a counter-
current immunoelectrophoresis (CIEP) test. In 2005, the Finnish Fur Breeders’ 
Association implemented an eradication program that required the development of a new 
AMDV-detection protocol to screen ca. 600 000 samples per year. Although AMDV can 
infect and may cause disease in other mustelids and carnivores, little is known about the 
epidemiology and evolutionary relationships of AMDV strains in the wild in Finland and 
elsewhere. Thus, this study aimed to develop a modern automated test for the large-scale 
serodiagnosis of AMDV in mink and to elucidate the epidemiology and phylogeny of this 
virus in farmed mink and free-ranging mustelids in Finland. 
A new antigen for the serological test was developed with a recombinant DNA 
technique. The major capsid protein (VP2) gene of a Finnish AMDV strain obtained from 
a farmed mink was amplified, cloned into a baculovirus transfer vector with subsequent 
recombination to baculovirus genome, and expressed in insect cells. The antigen formed 
virus-like particles and was confirmed to be antigenic with several serological methods. 
Subsequently, an enzyme-linked immunosorbent assay (ELISA) was designed for the 
antigen and automated. Because the small glass capillaries used to collect blood samples 
in CIEP could not be utilized in the ELISA test, a wicking technique using a filter paper 
‘blood comb’ was developed. The performance of this test was compared to CIEP (an 
imperfect gold standard) by testing blood/serum samples from farmed mink. The results 
were analyzed with Bayesian modelling allowing for conditional dependence. The new 
automated ELISA test was found to be accurate with a diagnostic sensitivity of 96.2% 
(95% probability interval [PI], 91.5–99.0) and specificity of 98.4% (95% PI, 95.3–99.8), 
and was therefore determined suitable for the serodiagnosis of AMDV. 
The epidemiology and phylogenetics of AMDV were inferred from organ and/or blood 
samples from farmed mink and free-ranging mustelids. The samples were screened with 
the newly-developed ELISA (described above) or CIEP test for anti-AMDV antibodies 
and with previously described or newly-developed PCR assays for AMDV DNA. Test 
results were studied with statistical, phylogenetic, and sequence analysis methods. 
Aleutian mink disease virus was found to be prevalent in the wild in Finland. A new host 
species, the European badger (Meles meles), with a prevalence of 27% (7/26; 95% 
confidence interval [CI], 13–46), was identified. In addition to the badger, infection 
markers were found in 54% (31/57; 95% CI, 42–67) of feral American mink and in one 
European polecat (Mustela putorius) (1/14; 95% CI, 1–29). No infection was found in 
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Eurasian otters (Lutra lutra) (24; 95% CI, 0–10), European pine martens (Martes martes) 
(183; 95% CI 0–1), least weasels (Mustela nivalis) (2; 95% CI, 0–67), stoat (Mustela 
erminea) (1; 95% CI, 0–85), or wolverine (Gulo gulo) (1; 95% CI, 0–85). Positive animals 
were distributed throughout western, southern, and eastern Finland (10/17 of sampled 
regions). American mink (odds ratio [OR], 335) and badger (OR, 74) had higher odds of 
infection compared to other species. Also, animals sampled during the first sampling 
period (2006–2009; OR, 5) had higher odds of infection compared to the second period 
(2010–2014). No significant association was detected between infection and age, sex, or 
region. Furthermore, mink farms were not associated with higher odds of AMDV 
infection nor appeared to serve as a major source of infection for free-ranging mustelids at 
the municipal or regional level. Based on these results, it appears that domestic and 
sylvatic transmission pathways are largely decoupled, but it seems probable that infections 
occasionally move between the farmed and wild populations (e.g., via infected 
escapees/intruders). A phylogenetic analysis, including Finnish, Estonian, and global 
strains, indicated that AMDV strains form at least five main clusters. It also inferred that 
the virus has been introduced to Finnish farms on at least three occasions. Unfortunately, 
it could not be discerned whether the occurrence of AMDV in Finland is natural or a 
consequence of the global mink trade. In addition to its main hosts (farmed and wild 
mink), similar strains of AMDV were found in pine martens, polecats, and badgers. 
Interestingly, Estonian badgers carried a divergent strain, possibly representing a new 
amdoparvovirus. Other than the strain found in Estonian badgers, and the tendency of 
strains from Finnish farmed and feral mink to diverge into separate clusters, AMDV 
strains did not cluster according to location, year, species, or pathogenicity. The nucleotide 
differences between Finnish AMDV sequences, based on partial non-structural protein 1 
gene, ranged from 0% to 14% and similar levels of variability were observed in farmed 
and natural populations. 
As a result of these studies, an automated ELISA test for the serodiagnosis of AMDV 
was developed and validated with high diagnostic sensitivity and specificity. The test 
offers a low cost, easy sampling, rapid throughput of large sample numbers, reduced 
processing time, and automated data management. The new test can be utilized for the 
monitoring, control and eradication of the virus, calculating the seroprevalence, and 
confirming the infection status of farms or individual mink. In addition, new information 
on AMDV epidemiology and genetic variation in Finnish farmed mink and free-ranging 
mustelids were established with potential impact on the biosecurity of farms, outbreak 
investigations, and the conservation of threatened mustelid species. Moreover, the new 
diagnostic tools and additional sequence data generated in this study can be utilized in the 
future research on the epidemiology of AMDV. 
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1. Introduction 
Aleutian mink disease virus (AMDV, family Parvoviridae) is a small and structurally 
simple virus with an icosahedral and non-enveloped capsid containing a short 
deoxyribonucleic acid (DNA) genome. Despite its apparent simplicity, the virus can cause 
a variety of potentially fatal disease symptoms (Aleutian disease, AD; also referred to as 
plasmacytosis and Sapphire disease). These range from an acute respiratory disease in kits 
to persistent and progressive immune complex-mediated disease in adults (reviewed by 
Bloom et al., 1994). Aleutian disease mainly affects American mink (Neovison vison), but 
other mustelid and carnivore species may also become infected (reviewed by Farid, 2013; 
reviewed by Nituch et al., 2015). The disease was first identified in farmed Aleutian 
genotype mink (with silver-grayish fur) in North America in the 1940s (Hartsough and 
Gorham, 1956), but has subsequently been found across the world in several mink-
producing countries and in the wild (reviewed by Farid, 2013; reviewed by Nituch et al., 
2015). Aleutian disease is an economically and ecologically important problem affecting 
animal welfare and health. It poses a significant financial threat to farmers (Aasted, 1985) 
and, potentially, indigenous wild mustelid species (Mañas et al., 2001; Yamaguchi and 
Macdonald, 2001; Fournier-Chambrillon et al., 2004; Nituch et al., 2012). Once a farm is 
infected, the disease is difficult to eradicate as the virus is transmitted through vertical, 
horizontal, direct and indirect routes (reviewed by Gorham et al., 1976), is resistant to 
many disinfectants and environmental conditions, and no effective treatment or vaccine 
currently exists (reviewed by Hussain et al., 2014). Currently, the prevention and control 
of AD in farms relies on early detection and culling of infected animals or entire herds, as 
well as the implementation of and adherence to effective biosecurity measures (Cho and 
Greenfield, 1978; Gunnarsson, 2001; Prieto et al., 2014).  
Effective disease control and eradication programs rely on the development and 
application of new diagnostic tests1. When a particular test has been used for an extended 
period of time in a successful eradication program with decreasing prevalence, an 
increasing number of false-positive animals will be culled and new test systems should be 
developed (Thrusfield, 2007a). The detection of AMDV in mink has, since the late 1970s, 
mainly been based on screening for the presence of anti-AMDV antibodies using a 
counter-current immunoelectrophoresis (CIEP) test (Cho and Ingram, 1972). CIEP 
employs agarose gel electrophoresis to resolve a precipitin line formed by the antigen and 
the antibodies in a serum sample (Cho and Ingram, 1972). Although a simple, rapid and 
inexpensive method for small batches, it is not well-suited to automation and requires a 
large amount of labor. Published studies describing a thorough validation of this test are 
lacking, but estimates of diagnostic sensitivity (DSe) vary from 79% to 99% and 
diagnostic specificity (DSp) from 90% to 100% (Wright and Wilkie, 1982; Aasted et al., 
1986; Jensen et al., 2011; Dam-Tuxen et al., 2014). 
Finland is one of the major global producers of mink pelts, with approximately two 
million pelts with a sales value of 57 million euros in 2014 (P. Aronen [Fin Furlab], 
personal communication 27.5.2015). About 400 farms and 400 000 breeding mink are 
mainly located in western Finland (Profur, 2014). In Finland, the CIEP test has been in use 
                                                 
1 Test, assay, and method are used interchangeably in the text. 
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since 1980. The mean AMDV seroprevalence of all mink tested ranged between 3% and 
60% during 1980–2014, being higher during the earlier years and around 10% more 
recently (Kangas and Smeds, 1980s, M. Eerola [Fin Furlab], personal communication 
21.5.2015). The implementation of an eradication program in 2005 by the Finnish Fur 
Breeders' Association (STKL) led to an increase in sample numbers from 330 000 to over 
700 000 annually, with a concomitant requirement for additional labor and shortages of 
the CIEP antigen. Thus, an accurate, simple, economical, and high-throughput test was 
needed with the possibility for automation and employment of a new antigen. 
In addition to farmed and feral American mink, viral DNA and/or antibodies have also 
been detected in several other mustelids and carnivores in Europe, North America, and 
Japan (Murakami et al., 2001; reviewed by Farid, 2013; reviewed by Nituch et al., 2015). 
Although research concerning the molecular epidemiology of various virus strains in 
captive and wild/feral mink has increased recently, data concerning the virus in other 
mustelids and carnivores remain scarce. Details concerning the clinical disease, 
pathogenicity, epidemiology, and phylogenetics of this virus in wild mustelids have yet to 
be established. The full range of host species, the prevalence of infection, and the risk 
factors for infection in these species are also unknown, and given that data are only 
available from a few countries the geographical distribution of AMDV is likely much 
greater than currently recognized. A few studies have indicated that infected mink farms 
may play a role in the transmission of the virus to the local natural population, and 
conversely wild or feral animals may carry the virus into farms (Oie et al., 1996; Nituch et 
al., 2011; Nituch et al., 2012). Further research is needed to clarify the sylvatic and 
domestic transmission cycles and the extent of their interaction. The origin of AMDV is 
unknown. Despite of its first detection and description in farmed mink of North America, 
it may be simple to assume that the virus originated there (Farid, 2013). However, AMDV 
might have existed in wild mink (and/or other mustelid) populations of North America (or 
elsewhere) long before its detection in farmed mink (Gorham et al., 1976). It is also 
possible that other mustelid species carry distinct and novel amdoparvoviruses in addition 
to AMDV. Notably, these viruses have already been identified in foxes (Urocyon 
cinereoargenteus, Vulpes lagopus, and V. vulpes) and raccoon dogs (Nyctereutes 
procyonoides) (Li et al., 2011; Shao et al., 2014; Bodewes et al., 2014a). 
In Finland, data on the epidemiology and phylogenetics of AMDV both in farmed 
mink and free-ranging2 mustelids were practically non-existent. Potential host species, in 
addition to farmed and feral mink, include the seven indigenous mustelids, of which the 
wolverine (Gulo gulo) is critically endangered and the polecat (Mustela putorius) is 
considered vulnerable (Liukko et al., 2010). 
The aims of these studies were to develop the serodiagnostics of AMDV and elucidate 
the epidemiology and phylogenetics of the virus in Finnish farmed mink and free-ranging 
mustelids. Specifically, the aims were to construct a new recombinant antigen with which 
to develop, automate, and validate a serological assay for detecting anti-AMDV antibodies 
in blood of farmed mink, and to develop a simple blood sampling method for this assay. 
Due to the potential impacts on conservation and eradication efforts, it was also important 
                                                 
2 The term free-ranging refers to both wild and feral animals in the natural environment. Feral refers to 
a free-ranging animal that descends from domesticated ancestors that escaped or were intentionally 
released and have subsequently reproduced in the wild. 
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to determine whether AMDV (and/or related viruses) occurs in the Finnish natural 
environment and, if so, to clarify the host species, prevalence, geographical distribution, 
and determine any factors associated with infection. Furthermore, the origin, evolutionary 
relationships, and diversity of AMDV strains in farmed mink and free-ranging mustelids 
were studied in relation to global diversity, geographical and temporal distribution, 
transmission routes, pathogenicity, and the extent of genetic variation. 
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2. Literature review 
2.1. Mink, mustelids, and mink farming 
Mustelidae, comprising 57 species, is the largest family within the order Carnivora 
(reviewed by Larivère and Jennings, 2009). Mustelids usually have long bodies and short 
legs, and range in size from just 25 g for the least weasel (M. nivalis) to 45 kg for the sea 
otter (Enhydra lutris) (reviewed by Larivère and Jennings, 2009). They live in diverse 
habitats from seas and rivers to forests and grasslands. While most mustelids are terrestrial 
carnivores, there are also aquatic and fossorial examples (reviewed by Larivère and 
Jennings, 2009). Mustelids can be found on all continents except Antarctica (reviewed by 
Larivère and Jennings, 2009). Several species are listed as endangered by the International 
Union for Conservation of Nature (IUCN, 2014). Seven mustelid species are native to 
Finland: the European pine marten (Martes martes), European polecat, European badger 
(Meles meles), Eurasian otter (Lutra lutra), wolverine (Gulo gulo), least weasel, and stoat 
(M. erminea). Of these, the wolverine is critically endangered and the polecat is 
considered vulnerable (Liukko et al., 2010). European mink (M. lutreola) regrettably 
became extinct in Finland in the second half of the 20th century (Henttonen, 1992), and 
populations have also been in drastic decline elsewhere in Europe (reviewed by Maran and 
Henttonen, 1995). It has been speculated that the decline might in part be due to an 
infectious disease transmitted by the American mink, although several other possible 
reasons also exist (reviewed by Maran and Henttonen, 1995). The pine marten, otter, least 
weasel, and stoat are present throughout Finland, whereas the polecat is mainly found in 
the east and south-east, the badger in the south, and the wolverine in the east, west, and 
north (Luke, 2013; SYKE, 2014).  
The semi-aquatic American mink is native to North America but has spread into 
several European countries, Russia, Japan, South America, and parts of Asia via the 
escape and/or deliberate release of farmed animals (reviewed by Reid and Helgen, 2008; 
reviewed by Larivère and Jennings, 2009). Farmed mink is a combination of several sub-
species of the American mink: mainly Eastern (N. vison vison), Kenai (N. vison 
melampeplus), Alaska mink (N. vison ingens), and to a lesser extent the common (N. vison 
mink), Hudson Bay (N. vison lacustris), and Pacific mink (N. vison energumenos) 
(Shackelford, 1957). It has been farmed for its fur for decades and different traits, such as 
fur color (from white to black) and quality, size, and temperament, have been emphasized 
(Nes et al., 1988). American mink is an introduced species in Finland and the population 
in the wild is a result of escapees from farms and deliberate release in European parts of 
Russia (reviewed by Kauhala, 1996). Soon after the establishment of mink farming in 
Finland, the first mink were observed in the wild (Westman, 1966). In the 1950s, they 
were mainly present in the western and south-western coast of Finland (Westman, 1966), 
but today feral mink are found throughout the country (Kauhala, 1996).  
Unfortunately, initial breeding trials with mink were not recorded, but the first farms 
were established in the 1920s in Canada, USA, and Scandinavia (Lund, 1979). In Finland, 
the first mink farm was established in the early 1930s (Lund, 1979). No precise records 
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exist concerning the trade and movement of breeding mink in Finland during the 
establishment of mink farming (E. Smeds [STKL], personal communication 28.9.2006; E. 
Puotila [Ministry of Agriculture and Forestry], personal communication 15.7.2015; P. 
Lappalainen [Customs], personal communication 27.7.2015), but it is probable that the 
first mink were imported mainly from the USA and later from Denmark and Sweden (E. 
Smeds [STKL], personal communication 28.9.2006). Over the years, most mink have 
been imported from Denmark, USA and Canada (L. Finne [STKL], personal 
communication 1.2.2007). Finnish farmers have exported mink mainly to Russia, Poland, 
and China (L. Finne [STKL], personal communication 1.2.2007). With nearly two million 
pelts per year (2013), Finland is one of the major global mink producing countries along 
with the USA, the Netherlands, Canada, Denmark, Poland, Russia, and China (Profur, 
2014). Finnish pelts are produced by approximately 400 000 breeding mink housed at 400 
farms (2013) (Profur, 2014). About 95% of these farms are located in four administrative 
regions3 in western Finland: Ostrobothnia, North, Central, and South Ostrobothnia (A. 
Kettunen [STKL], personal communication, 10.6.2014). Mink are mated and the kits are 
born in the spring (STKL, 2015a). The winter fur develops during the fall and breeding 
animals for the next season are selected in the late-autumn and the remaining animals are 
pelted (STKL, 2015a). 
2.2. Parvoviruses 
The Parvoviridae family consists of two subfamilies: Parvovirinae with viruses of 
vertebrates; and Densovirinae with viruses of arthropods (Tijssen et al., 2011). The 
Parvovirinae subfamily is divided into eight genera: Amdoparvovirus, Aveparvovirus, 
Bocaparvovirus, Copiparvovirus, Dependoparvovirus, Erythroparvovirus, 
Protoparvovirus, and Tetraparvovirus (ICTV, 2014). The diseases that parvoviruses cause 
in animals range from subclinical to severe gastroenteritis, myositis, myocarditis, 
hepatitis, pneumonia, leukopenia, and chronic immune complex disease (reviewed by 
Parrish, 2011). They may also cause congenital fetal anomalies and reproductive failure 
(reviewed by Parrish, 2011). Viruses of major veterinary importance are mainly found in 
the Protoparvovirus and Amdoparvovirus genera, such as feline panleukopenia virus 
(FPV), canine parvovirus type 2 (CPV2), mink enteritis virus (MEV), porcine parvovirus 
(PPV), and AMDV. Feline panleukopenia virus, CPV2, and MEV belong to the same 
species of Carnivore protoparvovirus 1 (ICTV, 2014). Partly due to the advent of new 
molecular techniques (e.g., next-generation sequencing) several new parvovirus species, 
such as human parvovirus 4 (PARV4), human bufavirus, porcine hokovirus (PPV3), ovine 
partetravirus, canine bocavirus 2, and gray fox amdovirus, have been found in animals and 
humans in recent years (Li et al., 2011; reviewed by Ni et al., 2014; Yahiro et al., 2014; 
Bodewes et al., 2014b). However, in some cases their ability to cause disease is unclear. 
Parvoviruses are small (diameter ranging from 21.5 to 25.5 nm) non-enveloped viruses 
with icosahedral symmetry (reviewed by Tijssen et al., 2011). The single-stranded DNA 
genome is linear, non-segmented, and 4–6.3 kilobases (kb) in size (reviewed by Tijssen et 
                                                 
3 Finland is divided into 320 municipalities and 19 administrative regions (see also Figure 5 for map). 
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al., 2011). The palindromic sequences at both ends can form hairpin structures needed for 
viral replication (reviewed by Tijssen et al., 2011). Generally, parvoviruses utilize 
receptor-mediated endocytosis to enter the cell and various modes of trafficking within the 
cell (reviewed by Tijssen et al., 2011). The parvoviruses usually have two open reading 
frames (ORF): the left REP ORF encoding non-structural (NS) proteins and right CP ORF 
for structural proteins (CAP, VP, or S) (reviewed by Tijssen et al., 2011). To create 
different gene products from these ORFs, some parvoviruses use alternative splicing, 
leaky scanning and/or alternative polyadenylation (reviewed by Tijssen et al., 2011).  
For replication, which takes place in the nucleus, autonomous parvoviruses require 
dividing cells that are going through mitotic S-phase (reviewed by Parrish, 2011; reviewed 
by Tijssen et al., 2011). Certain parvoviruses (genus Dependoparvovirus) are replication 
defective and need the presence of a helper virus, such as an adenovirus or herpesvirus, to 
replicate efficiently (reviewed by Tijssen et al., 2011; reviewed by Parrish, 2011). As 
fetuses and neonates have a relatively large proportion of mitotically-active cells, they are 
often more susceptible to diseases caused by parvoviruses (reviewed by Parrish, 2011). 
Thus, parvoviruses tend to have a tropism to certain rapidly-dividing cells and tissues, 
such as hematopoietic precursors and lymphocytes, progenitor cells of the intestinal 
mucosa, as well as external granular layer of the cerebellum and myocytes in the heart in 
early life (Parrish, 2011). Typically, parvoviruses cause permissive and acute infections 
(e.g. FPV, CPV2, and MEV) that last only few days, but some are able persist for long 
periods, even for life (e.g. AMDV, porcine parvovirus, and B19) (reviewed by Söderlund-
Venermo et al., 2002; reviewed by Parrish, 2011). 
2.3. Aleutian mink disease virus 
Aleutian mink disease virus belongs to the species of Carnivore amdoparvovirus 1. 
Together with Carnivore amdoparvovirus 2 (gray fox amdovirus), they are currently the 
sole members of the genus Amdoparvovirus (ICTV, 2014; Cotmore et al., 2014). 
However, novel amdoparvoviruses not yet listed in the International Committee on 
Taxonomy of Viruses (ICTV) have been recently found in arctic and red foxes and 
raccoon dogs (Shao et al., 2014; Bodewes et al., 2014a). 
2.3.1. Morphology, genome, and proteins 
Aleutian mink disease virus has a non-enveloped and icosahedral virion about 25 nm in 
diameter (reviewed by Cho, 1976). The single-stranded DNA genome is approximately 
4.7 kb in size with terminal hairpin structures and negative polarity (Bloom et al., 1990). 
The genome contains three ORFs which encode for five proteins: ORF1 encodes NS1 
protein with molecular weight of 70 kilodaltons (kDa); ORF2 encodes NS3 (10 kDa); and 
ORF3 encodes NS2 (17 kDa), structural proteins VP1 (85 kDa) and VP2 (75 kDa) (Qiu et 
al., 2006; Qiu et al., 2007; Huang et al., 2014). Six messenger RNAs (mRNA) are 
generated from one promoter (P3) by alternative splicing and polyadenylation (Qiu et al., 
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2006). The non-structural proteins share 60 amino acids at the N (amino)-terminus (Huang 
et al., 2014). The VP1 sequence contains the entire VP2 sequence with additional 44 
amino acids in its N-terminus (Christensen et al., 1993). 
In parvoviruses, the NS1 protein has several functions associated with viral replication, 
regulation of DNA replication, transcription and packaging of viral DNA, release and 
spread of virus progeny, transactivation of viral and cellular genes, DNA damage 
response, and enzymatic activities (nickase, helicase/ATPase) (reviewed by Tewary et al., 
2014; reviewed by Nuesch and Rommelaere, 2014). It also plays a role in the cell cycle 
arrest, modulation of host innate immunity, infectivity, cytotoxicity, and apoptosis 
(reviewed by Tewary et al., 2014; reviewed by Nuesch and Rommelaere, 2014). In 
AMDV, the NS1 protein is presumed to have similar functions, but it may also be 
involved in the restriction of virus replication and pathogenicity (Bloom et al., 1982; 
Huang et al., 2014). The smaller non-structural proteins, NS2 and NS3, are required for 
viral replication (Huang et al., 2014). The AMDV strains share over 87% nucleotide (nt) 
and 82% amino acid (aa) identities in the NS1 gene (Li et al., 2011). However, a higher 
degree of variability, up to 19% at the nt and 30% at the aa level, are seen within certain 
regions (Olofsson et al., 1999). The middle region of the protein is more conserved than 
the N- and C (carboxy)-termini (Gottschalck et al., 1994).  
The AMDV capsid is formed by VP1 and VP2 proteins. It contains 60 protein particles 
from which 10% are VP1 and 90% VP2 (McKenna et al., 1999). The VP2 gene seems to 
be more conserved than NS1 with over 92% nt and 91% aa identities (Li et al., 2011). 
Certain regions show a divergence of up to 11% at the nt and 15% at the aa level (Oie et 
al., 1996; Nituch et al., 2012). Variable nt positions are clustered within an area known as 
the hypervariable region at nt 690–730, MU 64–65 (Gottschalck et al., 1991; Gottschalck 
et al., 1994; Oie et al., 1996). Generally in parvoviruses, the capsid surface has a major 
role in determining the pathogenicity, along with the antigenicity, host range, and cellular 
tropism (McKenna et al., 1999; reviewed by Kontou et al., 2005). It appears that a 
particular region of the AMDV VP2 sequence (residues 428–446 in the icosahedral 
twofold depression) is involved in the pathogenesis of AD, i.e., immune complex 
formation and antibody-dependent enhancement of infection (ADE) (Bloom et al., 2001). 
In addition to this site, other specific regions in the capsid proteins (e.g., valine residue at 
codon 352, aspartic acid at 534, residues in the two- and threefold axes, map units [MU] 
54–65, MU 64–65, and MU 65–88) may contribute to the pathogenicity, replication, 
and/or determination of the host range (Bloom et al., 1988; Gottschalck et al., 1991; 
Bloom et al., 1993; Bloom et al., 1998; Fox et al., 1999; McKenna et al., 1999; Bloom et 
al., 2001; McCrackin Stevenson et al., 2001).  
2.3.2. Replication and persistence 
Aleutian mink disease virus is an autonomous parvovirus, i.e., replication can take place 
without the need for a helper virus. Replication is restricted in adult mink, which creates a 
persistent and non-cytopathic infection (Alexandersen et al., 1988; Alexandersen et al., 
1989). Cytopathic and permissive replication is known to occur only in seronegative mink 
kits (in type II pneumocytes) and in Crandell feline kidney (CRFK) cells (Bloom et al., 
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1980; Alexandersen et al., 1987; Alexandersen and Bloom, 1987; Alexandersen et al., 
1989). The primary sites for replication in adults are B-lymphocytes, macrophages, and 
dendritic cells in lymphoid organs (primarily lymph nodes and spleen) (Alexandersen et 
al., 1988; Wohlsein et al., 1990; Mori et al., 1991; Aasted and Leslie, 1991; Kanno et al., 
1992). Some replication may also occur in the blood leukocytes and bone marrow of 
adults and in the liver and kidney of kits (Alexandersen et al., 1987; Alexandersen et al., 
1988). The entry of AMDV into target cells is likely to occur via ADE, where virus-
antibody complexes bind to cellular Fc-receptors that facilitate viral entry into the cell 
(Kanno et al., 1993; Bloom et al., 2001). Mechanisms for viral persistence and restricted 
replication appear to be associated with non-neutralizing antibodies, ADE, functions of the 
non-structural proteins, restriction of capsid protein production by caspase cleavage, and 
internal polyadenylation of pre-mRNA (Kanno et al., 1993; Alexandersen et al., 1994a; 
reviewed by Best and Bloom, 2005; Cheng et al., 2010; Huang et al., 2012). The 
permissive replication in CRFK cells seems to be facilitated by apoptosis and caspase 
activity (particularly caspase-3) (Best et al., 2002). 
In kits and adults, the level of viral replication typically peaks 9 to 14 days post-
infection (p.i.) (Porter et al., 1969; Alexandersen and Bloom, 1987; Alexandersen et al., 
1988), after which the number of cells producing the virus decreases considerably 
(Alexandersen et al., 1988). The virus can first be detected from 4 to 14 days p.i., 
primarily in the spleen and lymph nodes of adults and in the lungs of kits, but to some 
extent (mainly in the form of sequestered virion DNA) also in the intestine, kidney, bone 
marrow, liver, blood, plasma/serum, and brain (Gorham et al., 1964; Eklund et al., 1968; 
Hadlow et al., 1985; Alexandersen et al., 1987; Alexandersen et al., 1988; Oie et al., 1996; 
Jahns et al., 2010; Jensen et al., 2014; Farid et al., 2015). Even in asymptomatic mink, the 
virus can persist in tissues for several months, possibly for life (Eklund et al., 1968; 
Hadlow et al., 1985; Oie et al., 1996), although it seems that some non-Aleutian mink are 
able to clear the virus (Hadlow et al., 1984). Viremia develops five days to four weeks p.i. 
and appears to persist in Aleutian mink infected with highly pathogenic strains, whereas 
mink (especially non-Aleutian) infected with low pathogenicity strains may develop only 
transient or intermittent viremia (Eklund et al., 1968; Hadlow et al., 1985; Oie et al., 1996; 
Jackson et al., 1996a; Jensen et al., 2014). Following an antibody response, the viremia 
seems to decrease (Jackson et al., 1996a). However, the onset of infection and viremia, 
and the level of virus replication vary greatly among individuals (Hadlow et al., 1985). 
2.3.3. Propagation and cultivation 
Aleutian mink disease virus is propagated in cell culture or in mink. However, only a few 
strains (e.g., AMDV-G, -P, and -GL) are adapted to grow in cell culture, more specifically 
in feline renal epithelial (CRFK) cells at 31.8  °C (Porter et al., 1977b; Bloom et al., 1980; 
Alexandersen, 1990). Most of the cultivable strains originate from the highly pathogenic 
Utah 1 strain (Bloom et al., 1980). Of these the non-pathogenic AMDV-G, isolated in the 
late 1970s, has become the most widely used for research and diagnostic purposes as it 
grows to higher titers than most other strains (Bloom et al., 1980). After several passages 
in cell culture, AMDV-G has lost its pathogenicity to mink (Bloom et al., 1980; Oie et al., 
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1996). As the cultivation of field strains in cell culture is often unsuccessful (reviewed by 
Porter et al., 1977b), most AMDV strains are propagated in live mink. The mink are 
usually infected with intraperitoneal injections and euthanized ten days p.i. (reviewed by 
Cho, 1976). 
2.3.4. Different strains and their pathogenicity 
Aleutian mink disease virus strains can be categorized roughly into four classes based on 
their pathogenicity4 to mink: non, low, moderate, and high (Table 1). All strains infect 
both Aleutian and non-Aleutian mink, some strains only cause disease in Aleutian mink 
whereas others induce severe symptoms and lesions in mink of all genotypes (Hadlow et 
al., 1983). It seems that strains do not differ in the severity (i.e., virulence) of the disease 
they cause; rather, the genotype of the mink plays a more important role. The final level of 
hypergammaglobulinemia and terminal pathology seem to be similar in different strains 
(Hadlow et al., 1983; Alexandersen et al., 1994b). However, highly pathogenic strains 
may induce higher levels of hypergammaglobulinemia and severe lesions sooner (Hyllseth 
et al., 1992; Alexandersen et al., 1994b), thus meaning a faster progression. Field strains 
appear to be mostly of low to moderate pathogenicity (Gorham et al., 1976; Hadlow et al., 
1983; Porter, 1986), but occasionally severe, rapidly spreading outbreaks occur, such as in 
the case of AMDV-K and -TR (Henson et al., 1976; Alexandersen, 1990; Oie et al., 1996). 
The determinants of AMDV pathogenicity have been extensively studied (see Chapter 
2.3.1) and although some have been identified, mainly in specific regions of the capsid, 
they seem to be complex and in need of further research.  
No official strain-demarcation criterion currently exists for AMDV and all isolates 
seem to be similar antigenically (reviewed by Tijssen et al., 2011). The classification in 
Table 1 is mainly based on clinicopathologic observations and later on sequence data. 
Serologically, strains are closely related (Aasted et al., 1984a). Gottschalck et al. (1991) 
proposed a typing scheme based on the amount of nucleotide differences between strains, 
where strains with minor differences were of the same type and with major differences of 
different type. AMDV-G, -SL3, and -TR were type 1, -Utah 1 type 2, -K type 3, and -
United type 4 (Gottschalck et al., 1991; Gottschalck et al., 1994; Oie et al., 1996; 
Schuierer et al., 1997). However, this typing scheme was based on only a few strains, does 
not correlate with pathogenicity (Oie et al., 1996; Schuierer et al., 1997), and no objective 
limits were proposed for the amount of nucleotide differences between different types. 
More recently, Christensen et al. (2011) used a molecular typing scheme for categorizing 
Danish strains based on differences in the NS1 gene. Whether this can also be used on a 
global scale remains to be determined. 
                                                 
4 Pathogenicity, ability of the organism to cause disease; virulence, severity of the disease caused by the 
organism. 
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2.3.5. Transmission 
Aleutian mink disease virus takes advantage of multiple modes of transmission. Mink may 
become infected vertically through placenta, or horizontally via indirect and direct 
transmission pathways (Padgett et al., 1967; reviewed by Gorham et al., 1976; Porter et 
al., 1977a; Broll and Alexandersen, 1996). Aleutian mink disease virus can be found in the 
feces, urine, blood, serum, and saliva of infected animals (Gorham et al., 1964; Jensen et 
al., 2014; Farid et al., 2015). Horizontal transmission occurs via peroral and saliva-
aerosol-respiratory routes either in direct contact with an infected mink (or other animals) 
or in indirect contact with contaminated feed, water, air, pens, equipment, and vehicles 
(Gorham et al., 1964; reviewed by Gorham et al., 1976; Jackson et al., 1996a; Jackson et 
al., 1996b). Infection may also be transmitted by iatrogenic route (e.g., toenail clippers), 
biting, and possibly insects (reviewed by Gorham et al., 1976; Cho and Greenfield, 1978; 
Jackson et al., 1996a). Airborne transmission has also been suggested as a mode of 
transmission between farms (Jackson et al., 1996b), but this has not yet been verified 
(reviewed by Jensen et al., 2014) and its role is probably unimportant (Christensen et al., 
2011; Espregueira Themudo et al., 2012).  
The rate of transmission within and between farms may vary considerably depending 
on the pathogenicity of the virus strain (Gorham et al., 1964; Gorham et al., 1976; Cho 
and Greenfield, 1978; Oie et al., 1996) and the genotype of mink being raised (Cho and 
Greenfield, 1978). Thus, even within one farm the seroprevalence might be as high as 
80% in one shed and less than 4% in another (Cho and Greenfield, 1978). AMDV strains 
of low pathogenicity seem less easily transmitted, as mink caged next to an infected 
individual or even experimentally-inoculated animals may remain uninfected (Gorham et 
al., 1964; Eklund et al., 1968; Bloom et al., 1975; Gorham et al., 1976; Cho and 
Greenfield, 1978; Hadlow et al., 1983; Oie et al., 1996; Jensen et al., 2014), or it may take 
three to four weeks for the infection to transmit from one cage to another (Jensen et al., 
2014). However, highly pathogenic strains may cause severe, rapidly spreading outbreaks 
where the herd of an AMDV-free farm can become 90% infected in less than six months 
(Alexandersen, 1990; Oie et al., 1996). It should be noted that farms and even individual 
mink may be infected with multiple strains (Hadlow et al., 1984; Gottschalck et al., 1991; 
Olofsson et al., 1999; Jahns et al., 2010). 
Research on the sylvatic transmission cycle and the transmission between farms and 
the wild has been scarce, but increasing in recent years. Some infer that wild/feral animals 
have separate cycles (Leimann et al., 2015), whereas others show that cross-infections 
between wild and captive populations do occur (Oie et al., 1996; Nituch et al., 2011; 
Nituch et al., 2012; Nituch et al., 2015). 
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2.4. Aleutian disease 
2.4.1. History 
The first case of AD was identified in 1946 in North America (Hartsough and Gorham, 
1956). It was initially described in mink with Aleutian (silver-grayish) coat color, named 
after Aleutian fox of a similar color. Viral etiology was proposed in the early 1960s 
(Karstad and Pridham, 1962; Trautwein and Helmboldt, 1962) and in 1974, a parvovirus 
was suggested as the causative agent of AD (Cho and Ingram, 1974). It is possible that the 
emergence of a new and more susceptible host (i.e., the Aleutian genotype mink with 
lysosomal abnormality) brought about the clinical disease (Gorham et al., 1976). 
However, the virus might have been present in mink farms and in the wild before the 
disease emerged (Gorham et al., 1976). In the late 1950s and early 1960s, AD was also 
found in Sweden and Denmark (reviewed by Aasted, 1985). Today, it is present in many 
mink-producing countries (reviewed by Aasted, 1985) and the virus has also been detected 
in natural populations of mustelids (reviewed by Farid, 2013; reviewed by Nituch et al., 
2015). Initially, AD was believed to only affect Aleutian mink, but it was soon realized 
that all genotypes (e.g., standard dark, black, and pastel) were susceptible (reviewed by 
Aasted, 1985). Of the farmed genotypes, Aleutian mink are more prone to develop a more 
serious form of AD (Eklund et al., 1968; Bloom et al., 1975; Larsen and Porter, 1975; 
Hadlow et al., 1983; Oie et al., 1996). Costs to farmers and the industry include the loss of 
breeding animals and kits, infertility, reduced litter sizes, abortions, low-quality fur, 
restrictions to international trade, and costs related to control measures (Eklund et al., 
1968; Aasted, 1985; Alexandersen, 1986). In Denmark, losses to the mink industry were 
estimated to be approximately 10 million dollars per year (Aasted, 1985). In Finland, the 
annual costs are approximately from two to three million euros (P. Aronen [Fin Furlab], 
personal communication 27.5.2015). 
2.4.2. Pathogenesis 
Aleutian disease manifests along a severity continuum depending on viral (strain and 
dose) and host (immune status, age, and genotype) factors. The disease outcomes can be 
categorized as follows: 1) progressive, persistent, and fatal (‘classical AD’); 2) non-
progressive and persistent; 3) transient; and 4) acute fatal pneumonia in mink kits (Figure 
1) (reviewed by Bloom et al., 1994). Progressive disease is characterized by high antibody 
titers, hypergammaglobulinemia, and lesions induced by immune complexes; non-
progressive disease by lower antibody titers, lower levels of or no 
hypergammaglobulinemia, and no lesions; and transient by lower and decreasing antibody 
titers and no viremia with potential virus clearance (Larsen and Porter, 1975; Henson et 
al., 1976; Hadlow et al., 1984; reviewed by Porter, 1986; reviewed by Jackson et al., 
1996a). As much as 25% of non-Aleutian mink may experience transient infections 
(Larsen and Porter, 1975). 
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In adult mink, AMDV causes a disease that is different from what is typically seen in 
parvoviruses. The clinical signs and lesions are actually a result of the host immune 
response to the virus, rather than being caused by direct actions of the virus (reviewed by 
Porter, 1986). Aleutian disease develops when the circulating antigen-antibody complexes 
deposit in tissues and cause type III hypersensitivity reaction (reviewed by Parrish, 2011). 
The monocytic cells, consisting mainly of plasma cells, and immune complexes 
accumulate in the kidneys, liver, spleen, bone marrow, and arteries causing tissue injury 
(reviewed by Porter et al., 1980).  
Mink homozygous for the Aleutian gene (aa), and color crosses such as Sapphire 
(aapp) and Violet (aammpp), are more susceptible to AD (Eklund et al., 1968; Bloom et 
al., 1975; Hadlow et al., 1983; Anistoroaei et al., 2013). The diluted pigmentation of the 
fur is a result of a lysosomal disorder (Chédiak-Higashi syndrome) caused by a mutation 
in the lysosomal trafficking regulator (LYST) gene (Anistoroaei et al., 2013). Thus, a more 
rapid progression of the disease and higher mortality rates compared to non-Aleutian mink 
(Eklund et al., 1968; Bloom et al., 1975; Larsen and Porter, 1975; Hadlow et al., 1983) 
may be due to the syndrome (Anistoroaei et al., 2013). 
In seronegative mink kits less than three weeks old, the disease is acute and caused by 
viral injury to type II pneumocytes resulting in fatal interstitial pneumonia (Alexandersen, 
1986; Alexandersen et al., 1994b). Both strains of high and low pathogenicity can induce 
pneumonia, but with varying morbidity and mortality (Alexandersen, 1986; Alexandersen 
et al., 1994b). Kits that survive the infection develop classical AD (Alexandersen, 1986; 
Alexandersen et al., 1994b). Although antibodies are unable to neutralize AMDV, they 
restrict viral replication in type II pneumocytes (Alexandersen, 1986; Alexandersen et al., 
1989). Thus, kits with antibodies received from a seropositive dam or kits infected 
transplacentally do not develop pneumonia (Porter et al., 1977a; Alexandersen, 1986; 
Alexandersen et al., 1989). Instead, AMDV infection in these kits results in a prolonged 
and non-progressive AD with mild lesions (Porter et al., 1977a; Alexandersen, 1986; 
Alexandersen et al., 1989).  
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Figure 1. Disease outcomes of Aleutian disease related to virus strain, mink genotype (Aleutian, 
gray; non-Aleutian, black), and age. Abbreviations: AMDV; Aleutian mink disease virus, AD; Aleutian 
disease. Modified from (Knuuttila, 2007). Compiled from the following sources: (Larsen and Porter, 1975; Henson 
et al., 1976; Porter et al., 1977a; Hadlow et al., 1983; Hadlow et al., 1984; Alexandersen, 1986; Alexandersen and 
Bloom, 1987; Alexandersen et al., 1989; Alexandersen et al., 1994a; Alexandersen et al., 1994b; Oie et al., 1996). 
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2.4.3. Antibody response 
During AMDV infection, high levels of antibodies are produced and target structural and 
non-structural proteins, predominantly conformational epitopes (Bloom et al., 1982; 
Aasted and Bloom, 1984; Costello et al., 1999). Although abundant, these antibodies are 
unable to neutralize the virus (reviewed by Porter, 1986) and infection with one strain 
provides little protection to future infections by other strains (Hadlow et al., 1984). Both 
mink genotypes produce high-affinity antibodies, but in non-Aleutian mink the quality of 
the antibodies decreases and they become more heterogeneous as the disease progresses 
(Aasted and Bloom, 1984). Although highly pathogenic strains can induce high levels of 
hypergammaglobulinemia and production of anti-AMDV antibodies more rapidly than do 
strains of low pathogenicity (Hyllseth et al., 1992), the affinity of the antibodies seems to 
be lower (Aasted and Bloom, 1984). A progressive disease is related to higher antibody 
titers, higher hypergammaglobulinemia, and more severe lesions; whereas a non-
progressive disease is characterized by lower antibody titers with no 
hypergammaglobulinemia or lesions (Larsen and Porter, 1975; Henson et al., 1976; 
reviewed by Porter, 1986; reviewed by Jackson et al., 1996a). In kits, low or no 
production of antibodies is linked to permissive and high levels of replication resulting in 
an acute and severe disease, while a chronic disease develops where replication is 
restricted to a low level and antibody production is high (Alexandersen et al., 1989).  
Increased total serum protein, gammaglobulin, and IgG are evident from 15 to 18 days 
p.i. (Porter et al., 1984b). The first anti-AMDV antibody to appear is IgM, which starts to 
increase six days p.i. with low levels present in most mink for at least 85 days p.i. (Porter 
et al., 1984b). Also, low levels of AMDV-specific IgA can be found throughout the 
infection period (Porter et al., 1984b). Most of the gammaglobulin and anti-AMDV 
antibody is IgG, which is present by day 15 p.i. and rises throughout the disease process 
(Porter et al., 1984b; Aasted et al., 1984b). The increase in gammaglobulin is mainly a 
result of increased amounts of AMDV-specific antibodies, but anti-DNA antibodies are 
also produced (Henson et al., 1976; Hahn and Hahn, 1983; Porter et al., 1984a; Aasted et 
al., 1984b). Aleutian mink tend to have higher gammaglobulin and IgG levels (Porter et 
al., 1984b) and the antibody response in this genotype invariably leads to fatal disease 
contrary to non-Aleutian mink (Hadlow et al., 1983). Thus, in non-Aleutian mink, 
especially when infected with strains of low pathogenicity, the hypergammaglobulinemia 
may be transient and the level of AMDV-specific antibodies is lower and decreasing 
(Eklund et al., 1968; Larsen and Porter, 1975; Bloom et al., 1975; Henson et al., 1976; 
Hadlow et al., 1983; Aasted et al., 1984b). Regardless of this, antibodies persist for several 
years and possibly for life (Hadlow et al., 1983). 
2.4.4. Clinical signs and lesions 
Severity of clinical signs and the rate at which the disease develops varies greatly among 
individual mink (Eklund et al., 1968). Generally, the disease is more severe and the 
progression is faster in mink kits with pneumonia and in Aleutian mink (Eklund et al., 
1968; Henson et al., 1976; Hadlow et al., 1983; Alexandersen et al., 1994b), which usually 
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die after a few days (Alexandersen and Bloom, 1987) and from two to six months p.i., 
respectively (Eklund et al., 1968). Non-Aleutian mink, although persistently infected, 
rarely die before five months and may survive for several years up to a full life span (i.e., 
eight years) (reviewed by Porter et al., 1980; Hadlow et al., 1983). The first lesions in 
adults (plasmacytosis and lymphadenopathy) appear two weeks p.i. (Bloom et al., 1994) 
and in mink kits five days p.i. (Alexandersen and Bloom, 1987). Death in adults is often 
caused by renal failure or hemorrhageing (Eklund et al., 1968; Henson et al., 1976; 
reviewed by Porter et al., 1980). In addition to host and viral factors, environmental and 
physiological determinants may also have a substantial effect on the mortality rate 
associated with AD in mink farms (Eklund et al., 1968; Gorham et al., 1976). Table 2 
presents the clinical signs and gross and histopathologic lesions of AD in mink kits and 
adult mink.  
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2.4.5. Control, prevention, and treatment 
Currently, no legistlation exists for the control of AMDV (Decree of the Ministry of 
Agriculture and Forestry on Controlling Animal Diseases and Their Classification5, 
843/2013) in Finland and although it is not notifiable to the World Organisation for 
Animal Health (OIE, 2015), it is notifiable (Decree of the Ministry of Agriculture and 
Forestry on Reporting of Animal Diseases and Supplying of Microbial Strains5, 
1010/2013) to the Finnish authorities. Given that prevention and control are not mandated 
by government, they have been organized by the industry and its representative, the 
Finnish Fur Breeders’ Association (STKL). To improve animal health and welfare, and to 
reduce the financial losses to farmers due to the reproductive failure, smaller litters, loss of 
breeding animals, and low quality fur, STKL executed an AMDV eradication program in 
2005. Finnish Fur Breeders’ Association provides farmers with financial and advisory 
support to implement the control measures. Farms are categorized into groups A–E based 
on AMDV seroprevalence (STKL, 2015b). All listed farms test their breeding animals 
once or twice annually from January to February and/or from May to June (STKL, 
2015b). Group A-farms have zero test prevalence (Aronen, 2006). Group B-farms should 
not have more than 1 positive/1000, group C 2/1000, and group D 50/1000 breeding 
females (Aronen, 2006). Group E-farms have more than 50 positive/1000 breeding 
females (Aronen, 2006). 
The main strategies employed in the eradication program are the identification and 
culling of infected animals (test-and-remove) or culling the entire herd (stamping out) with 
thorough cleaning and disinfection of the premises, repopulation with AMDV-free 
animals, and strict biosecurity measures (Cho and Greenfield, 1978; Gunnarsson, 2001; 
Prieto et al., 2014). Of major importance is the prevention of reinfection, as infected farms 
are difficult to sanitize due to the stability of the virus in the environment, its multiple 
modes of transmission, persistent infections, and the lack of effective therapy. New 
outbreaks may occur due to inadequate disinfection of the premises or through contact 
with nearby infected farms (Themudo et al., 2011; Christensen et al., 2011; Espregueira 
Themudo et al., 2012; Farid et al., 2012). Thus, cooperation between farms is imperative 
for effective results. Other important points for AMDV control include replacement 
animals, visitors, shared workers, vehicles, feed, manure, equipment, and wild/feral 
animals (Oie et al., 1996; Gunnarsson, 2001; Christensen et al., 2011; Farid et al., 2012; 
Espregueira Themudo et al., 2012; Prieto et al., 2014). It seems that test-and-remove 
strategy, although effective in reducing the prevalence, has so far failed to eradicate the 
virus from infected farms (Farid et al., 2012). Many mink-producing countries (e.g., 
Denmark, Finland, Canada, and Iceland) have implemented programs to eradicate AMDV 
and have been able to reduce prevalence and sanitize individual farms and areas 
(Gunnarsson, 2001; Farid et al., 2012; Espregueira Themudo et al., 2012). However, the 
strict stamping-out policy employed in Iceland offers the only example of a strategy that 
                                                 
5 Unofficial translations from Finnish: Maa- ja metsätalousministeriön asetus vastustettavista 
eläintaudeista ja niiden luokittelusta MMMa 843/2013 and Maa- ja metsätalousministeriön asetus 
eläintautien ilmoittamisesta ja mikrobikantojen toimittamisesta MMMa 1010/2013. 
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has successfully eliminated the virus from farms (Gunnarsson, 2001). The Danish program 
has also been succesful and positive-testing farms are now confined to northern Denmark 
(Espregueira Themudo et al., 2012). In Finland, both strategies are applied and the 
eradication has been successful in individual farms and areas, which has led to an increase 
in the proportion of AMDV-free farms; from 32% in 2005 to 48% in 2014 (P. Aronen [Fin 
Furlab], personal communication 27.5.2015; M. Eerola [Fin Furlab], personal 
communication 21.5.2015). However, this improvement is against a backdrop of 
increasing mean seroprevalence (3% to 15% since 2006) (M. Eerola [Fin Furlab], personal 
communication 21.5.2015) probably brought about by the implementation of more 
extensive testing of heavily infected farms. 
Inactivation of AMDV is challenging. As a typical parvovirus, it is able to survive a 
variety of physical and chemical treatments, e.g., ether, fluorocarbon, pH 3, deoxycholic 
acid (a bile acid), protease and nuclease digestion, 1% chloramine, 2% 2-phenylphenol, 
and various heating protocols ranging from 56 °C for 30 min to 99.5 °C for 3 min 
(reviewed by Cho, 1976; Eterpi et al., 2009; reviewed by Hussain et al., 2014). On the 
other hand, AMDV is sensitive to 0.05 M NaOH, 0.5 M HCl, 0.5% iodine, 0.3% formalin 
treatment for 8 h, ultraviolet light, and heating to 80 °C for 24 h or 65 °C for three days 
(reviewed by Cho, 1976; Hussain et al., 2014). In the field conditions, AMDV can be 
inactivated by composting at 65 °C for four days (Hussain et al., 2014). Farm equipment 
and surfaces are typically disinfected with agents containing glutaraldehyde or oxidative 
substances (e.g., Virkon S or Parvocide), gas flame, and/or formalin gassing (Kankkonen, 
2006). 
Effective medical treatment and an AMDV vaccine are currently lacking. Trials to 
develop an inactivated virus or a VP1/VP2 protein vaccine have been unsuccessful, as the 
antibodies induced by the vaccine tend to generate a more severe disease and actually 
increase mortality once the animal is challenged with the live virus (Porter et al., 1972; 
Aasted et al., 1998). For the same reason, treatment with passive antibodies has failed 
(Porter et al., 1972). Mink immunized with NS1 protein and NS1 DNA vaccines (or a 
combination of both) exhibit less severe symptoms when challenged but only partial 
protection is achieved (Aasted et al., 1998; Castelruiz et al., 2005). Although AD can be 
treated with immunosuppressive or immunomodulatory drugs such as cyclophosphamide 
or corticosteroids, these have not been used in mink farming due to their high cost 
(Cheema et al., 1972). Thus, medical treatment and supportive care is usually applied only 
to important breeding animals and pets such as ferrets. Despite the treatment, the 
prognosis of AD is poor (Hillyer and Brown, 2000). 
The notion that some mink are resistant to infection is uncertain (Hadlow et al., 1983). 
Breeding programs that have crossed non-affected genotypes to improve AMDV 
resistance have been unsuccessful (Larsen and Porter, 1975; Henson et al., 1976). More 
recent results suggest that there may be some hereditary differences in susceptibility to 
AMDV infection, although heritability is low (Häkli, 2013). 
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2.5. Diagnostics 
2.5.1. Diagnostic tests and their accuracy 
Diagnostic tests of viral infections can be based on the identification of the virus, viral 
antigens, viral nucleic acids, or host antibodies (reviewed by MacLachlan and Dubovi, 
2011). Different serological methods can be used to detect virus-specific antibodies, such 
as enzyme-linked immunosorbent assay (ELISA), indirect immunofluorescence, serum 
neutralization, hemagglutination inhibition, complement fixation, Western blotting, and 
immunodiffusion (reviewed by MacLachlan and Dubovi, 2011). Given the large number 
of animals that must be screened, simple, cost efficient, and rapid tests with high DSe and 
DSp are required (reviewed by MacLachlan and Dubovi, 2011). ELISA tests that identify 
virus-specific antibodies and polymerase chain reaction (PCR) tests that detect viral 
nucleic acids are standard methods for diagnosing infections today (reviewed by 
MacLachlan and Dubovi, 2011). However, the technology supporting these techniques is 
under constant development and new test platforms, especially those that incorporate 
multiplexing, are likely to become available for routine diagnostics in the near future 
(reviewed by MacLachlan and Dubovi, 2011). 
Diagnostic assays should be designed and selected to serve a distinctive purpose(s), 
such as confirming disease-free status, monitoring and eradication, confirmation of a 
diagnosis, estimating prevalence, and/or identifying infected animals (OIE, 2013). In order 
to be validated for its purpose, the test should complete three stages of the validation 
pathway according to OIE standards. The stages include analytical (analytical sensitivity 
[ASe], specificity [ASp] and repeatability) and diagnostic characteristics (diagnostic 
sensitivity [DSe], specificity [DSp], and cut-off determination) and reproducibility (OIE, 
2013). The diagnostic characteristics of a new diagnostic test (index test) may be 
evaluated against a perfect reference standard, a so-called ‘gold standard’ (OIE, 2014). 
However, such a comparison is often difficult to make due to the lack of such a test or the 
high cost of the test procedure (OIE, 2014), and new tests are typically validated against 
an imperfect reference standard which may either be conditionally dependent (i.e., 
measurement of similar analytes, such as antibodies) or independent (OIE, 2014). 
Different methods of statistical analyses, such as latent class methods (e.g., maximum 
likelihood and Bayesian methods), can be used to correct the bias resulting from the 
dependence of these tests and imperfectness of the reference test (OIE, 2014). 
2.5.2. CIEP 
The mass screening for AMDV infections in farms is based on the detection of anti-
AMDV antibodies. The CIEP (additional abbreviations CCIE, CIE, and CCE) method has 
been used in most mink-producing countries for decades as the standard test for the 
serodiagnosis of AMDV (reviewed by Porter et al., 1980). From its first application in the 
1970s, the test was run with a whole-virus antigen propagated in mink (Cho and Ingram, 
1972), but since the 1980s cell-culture (CRFK) derived antigen (mainly AMDV-G strain) 
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has been preferred (Aasted and Cohn, 1982). The antigen has been commercially available 
in the USA (manufactured by United Vaccines, since ceased production) and in Denmark 
by the Antigen Laboratory of the Research Foundation of the Danish Fur Breeders’ 
Association (Danad antigen). In Finland, CIEP was used in Fin Furlab (Vaasa) from 1980 
until 2008. 
A positive test result is scored as a white precipitin line on an agarose gel (Cho and 
Ingram, 1972). It is formed by immune complexes when the negatively-charged antigen 
moves towards the anode and the positively-charged antibodies towards the cathode 
during electrophoresis (Cho and Ingram, 1972). A positive test result can usually be 
detected by CIEP from two to three weeks p.i., but may take as long as seven weeks in 
some cases (Hadlow et al., 1983; Hadlow et al., 1985; Jensen et al., 2014; Farid et al., 
2015). Although CIEP has been in use for several decades, thorough validation studies 
(e.g., according to OIE standards) have not been published. Estimates of the DSe range 
between 79% and 99% and DSp between 90% and 100% (Wright and Wilkie, 1982; 
Aasted et al., 1986; Jensen et al., 2011; Dam-Tuxen et al., 2014). Unpublished data of the 
Animal Health Lab (University of Guelph, Canada) suggest a DSe value of 98%, DSp of 
86% to 91%, and repeatability of 98% to 99% (reviewed by Nituch et al., 2011; reviewed 
by Bowman et al., 2014). Several studies indicate that CIEP gives lower titers than many 
other test methods and fails to identify low levels of antibodies during early stages of an 
infection (Crawford et al., 1977; Aasted and Cohn, 1982; Alexandersen and Hau, 1985; 
Alexandersen et al., 1985a; Aasted et al., 1986; Miroshnichenko et al., 1992; Farid et al., 
2015). 
2.5.3. Other diagnostic methods 
During the late 1960s to late 1980s, numerous non-specific (iodine agglutination test, 
serum electrophoresis, and glutaraldehyde test) and specific (immunofluorescence, 
indirect immunofluorescence, complement fixation, viral agglutination, in situ 
hybridization, ELISA, and CIEP) diagnostic tests were developed (reviewed by Gorham et 
al., 1976; reviewed by Porter et al., 1980; Wright and Wilkie, 1982; Alexandersen et al., 
1987; Bloom et al., 1989). The diagnosis of AMDV infection in mink can also be made 
based on the detection of AMDV DNA by PCR (Jensen et al., 2011), gross and 
histopathologic lesions (Eklund et al., 1968), and AMDV antigen in tissues by 
immunohistochemistry (Hammer et al., 2007). 
As a first screening test for AMDV, to detect hypergammaglobulinemia in mink with 
AMDV infection, farmers used the iodine agglutination test (IAT) (reviewed by Porter et 
al., 1980). For disease control and eradication purposes, this method was problematic as it 
gave a high proportion of false negative results and identified the positive animals only at 
a late stage of infection (Cho and Ingram, 1974). In addition to IAT, 
hypergammaglobulinemia (>20% of total serum protein) caused by AMDV can be 
identified with serum protein electrophoresis, which has been widely used in research 
(reviewed by Porter et al., 1980). 
For several years, development of the test mainly focused on improving the sensitivity 
and/or specificity of the CIEP test. Such tests as modified counterelectrophoresis 
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(Crawford et al., 1977), indirect counter-current electrophoresis (Aasted and Cohn, 1982), 
counter-current line absorption immunoelectrophoresis (CCLAIE) (Alexandersen et al., 
1985a; Aasted et al., 1986), additive CIEP (Uttenthal, 1992), and rocket line 
immunoelectrophoresis (RIA) (Alexandersen and Hau, 1985) were developed. The most 
sensitive (both DSe and ASe) of these electrophoretic assays seems to be the CCLAIE 
(Aasted et al., 1986).  
Except for IAT, these tests have not been commonly used for mass screening due to 
their high cost or large amount of processing time. Instead, they have been applied in 
confirmatory testing, individual animals and research. In recent years, the development of 
new assays for the diagnosis of AMDV infection has become more active. New ELISA 
and PCR-based tests are now available for mass screening and confirmation applications 
(studies II, III, IV, Jensen et al., 2011; Dam-Tuxen et al., 2014). 
2.6. Epidemiology and phylogenetics 
2.6.1. Host range, geographic distribution, and prevalence 
Clinical signs and lesions are mainly found in farmed and feral/wild American mink in 
many European and North American countries (Table 3). In farmed mink in Finland, the 
annual mean seroprevalence of all tested mink ranged between 3% and 60% (1980–2014) 
(Kangas and Smeds, 1980s, M. Eerola (Fin Furlab), personal communication 21.5.2015). 
When testing began in 1980, prevalence was as high as 50% to 60% (Kangas and Smeds, 
1980s). Nowadays, about 700 000 mink and almost 90% of farms are tested annually and 
the prevalence is approximately 15% (2014) (M. Eerola [Fin Furlab], personal 
communication 21.5.2015). Unfortunately, data for other mink-producing countries are 
scarce. 
Other species that may develop AD are the ferret (Mustela putorius furo) and striped 
skunk (Mephitis mephitis) (Porter et al., 1982; LaDouceur et al., 2014). Anti-AMDV 
antibodies and/or AMDV DNA have also been found in other mustelids, such as European 
mink, weasels, martens, polecats, and otters in Europe, North America, and Japan (for 
references, see Table 3 and Murakami et al. (2001)). In addition to Mustelidae, other 
carnivores such as common genets, raccoons, and foxes may become infected (see Table 3 
for references). Coyotes (Canis latrans), groundhogs (Marmota monax), fishers (Martes 
pennati), badgers (Meles meles), raccoon dogs (Nyctereutes procyonoides), beavers 
(Castor canadensis), muskrats (Ondatra zibethicus), and squirrels (Tamiasciurus 
hudsonicus) have been tested for antibodies and/or AMDV DNA, but none have so far 
been found (Ingram and Cho, 1974; Farid, 2013; Leimann et al., 2015). Although signs of 
AMDV infection have been detected in several of the species mentioned above, there is 
yet little evidence that the virus can cause disease or induce clinical symptoms and lesions. 
However, some indication of subclinical or mild disease exists in European mink 
(Fournier-Chambrillon et al., 2004). 
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Experimentally, AMDV has been inoculated into several species. Ferrets, stoats, 
fishers, American martens (Martes americana), raccoon dogs, raccoons, cats, dogs, blue 
foxes, mice, and rabbits all developed antibodies after inoculation (Kenyon et al., 1978; 
Porter et al., 1982; Alexandersen et al., 1985b; Oie et al., 1996). Of these species, 
evidence of viral replication was found in ferrets, raccoons, raccoon dogs and dogs (Porter 
et al., 1982; Alexandersen et al., 1985b; Oie et al., 1996). Additionally, mice and cats 
harboured infective virus in their tissues (Alexandersen et al., 1985b). Only ferrets and 
striped skunks developed histologic lesions resembling AD in mink (Kenyon et al., 1978; 
Porter et al., 1982; Alexandersen et al., 1985b; Oie et al., 1996). 
Anti-AMDV antibodies have also been found in humans (McGuire and Crawford, 
1980; Jepsen et al., 2009), often with no associated illness. A recent study found 
antibodies and AMDV DNA in two mink farmers, one with artheritis and the other with 
chronic glomerulonephritis (Jepsen et al., 2009). Also, two other suspected cases have 
been reported earlier (Chapman and Jimenez, 1963; Helmboldt et al., 1965). The diagnosis 
was based on clinical signs following exposure to mink and comparative pathology, but 
anti-AMDV antibody or AMDV DNA were not tested as such tests were unavailable at 
the time (Chapman and Jimenez, 1963; Helmboldt et al., 1965). The persistence of 
antibodies up to four years after the last contact with mink is a cause for concern (Jepsen 
et al., 2009), as it may indicate a persistence of the viral infection. However, whether this 
virus actually has any zoonotic potential needs further proof. 
 
Table 3. Prevalence and case descriptions of Aleutian mink disease virus infection in 
different animal species and humans 
Species Ab%a DNA%a Sampling 
year 
Country Method Lesionsb Reference 
Feral/wild 
American 
mink 
93 (60) 88 (60) 2009–2011 Canada CIEP, 
PCR 
ND (Farid, 
2013) 
 29 (208) 25 (183) 2005–2009 Canada CIEP, 
PCR 
ND (Nituch et 
al., 2011; 
Nituch et 
al., 2012) 
 55 (55) ND Early 
1970s 
Canada CIEP, HP Histologic 
lesions 
typical for 
AD (6/55) 
(Cho and 
Greenfield, 
1978) 
 55 (29) ND Early 
1970s 
Canada ND ND (Ingram and 
Cho, 1974) 
 46 (144) 58 (144) 2004–2009 Sweden ELISA, 
PCR 
Gross 
lesions 
typical for 
AD 
(6/144) 
(Persson et 
al., 2015) 
 3–45 (538) 0-32 (57) 1998–2009 Denmark CIEP, 
PCR 
ND (Jensen et 
al., 2012) 
 23 (75) ND 1996–2002 France CIEP, 
CCLAI 
Poor 
physical 
condition 
(2/5) 
(Fournier-
Chambrillon 
et al., 2004) 
 52 (27) ND Late 1990s England CIEP ND (Yamaguchi 
and 
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Species Ab%a DNA%a Sampling 
year 
Country Method Lesionsb Reference 
Macdonald, 
2001) 
        
 ND 15 (27) 2007–2010 Estonia PCR ND (Leimann et 
al., 2015) 
 0 (16) 40 (5) 1997–1999 Spain CIEP, 
PCR, HP 
Histologic 
lesions 
typical for 
AD (1/5) 
(Mañas et 
al., 2001) 
European 
mink 
0 (84) ND 2004–2005 Spain CIEP ND (Sanchez-
Migallon 
Guzman et 
al., 2008) 
 12 (99) ND 1996–2002 France CIEP, 
CCLAI 
Poor 
physical 
condition 
(3/14) 
(Fournier-
Chambrillon 
et al., 2004) 
 33 (9) 1/1b 1997–1999 Spain CIEP, 
PCR, HP 
No lesions 
(0/1) 
(Mañas et 
al., 2001) 
Polecat 11 (145) ND 1996–2002 France CIEP, 
CCLAI 
ND (Fournier-
Chambrillon 
et al., 2004) 
Stone 
marten 
24 (17) ND 1996–2002 France CIEP, 
CCLAI 
ND (Fournier-
Chambrillon 
et al., 2004) 
Pine 
marten 
6 (16) ND 1996–2002 France CIEP, 
CCLAI 
ND (Fournier-
Chambrillon 
et al., 2004) 
Common 
genet 
4 (68) ND 1996–2002 France CIEP, 
CCLAI 
ND (Fournier-
Chambrillon 
et al., 2004) 
Stoat 70 (61) 70 (61) 2009–2011 Canada CIEP, 
PCR 
ND (Farid, 
2013) 
River 
otter 
0 (59) 0 (59) 2011–2012 Canada CIEP, 
qPCR 
ND (Bowman et 
al., 2014) 
 18 (11) 18 (11) 2009–2011 Canada CIEP, 
PCR 
ND (Farid, 
2013) 
Ferret 9 (446) ND 1990–1991 England CIEP ND (Welchman 
Dde et al., 
1993) 
 42 (214) ND Late 
1970s–
early 
1980s 
USA IF ND (Porter et 
al., 1982) 
Striped 
skunk 
ND 7 (27) 2010–2013 USA PCR, 
ISH, 
necropsy, 
HP 
Mild to 
severe 
gross and 
histologic 
lesions 
similar to 
mink AD 
(7/27) 
(LaDouceur 
et al., 2014) 
 18 (22) 14 (22) 1990s USA CIEP, 
PCR 
ND (Oie et al., 
1996) 
 25 (8) 13 (8) 2009–2011 Canada CIEP, 
PCR 
ND (Farid, 
2013) 
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Species Ab%a DNA%a Sampling 
year 
Country Method Lesionsb Reference 
 41 (347) 32 (40) 2006–2008 Canada CIEP, 
PCR 
ND (Nituch et 
al., 2015) 
 65 (196) ND Early 
1970s 
Canada ND ND (Ingram and 
Cho, 1974) 
Raccoon 11 (85) 11 (85) 2009–2011 Canada CIEP, 
PCR 
ND (Farid, 
2013)  
 4 (27) ND Early 
1970s 
Canada ND ND (Ingram and 
Cho, 1974) 
Fox 2 (100) ND Early 
1970s 
Canada ND ND (Ingram and 
Cho, 1974) 
Bobcat 10 (20) 10 (20) 2009–2011 Canada CIEP, 
PCR 
ND (Farid, 
2013) 
Farmed 
mink 
15 (700 
000) 
ND 2014 Finland ELISA ND Eerola 2015 
(pers. 
comm.) 
 
 48–67 
(ND) 
ND 2005 China ND ND (reviewed 
by Li et al., 
2012) 
 5 (1500–
2500)c 
ND 2001 Denmark CIEP ND (Christensen 
et al., 2011; 
Espregueira 
Themudo et 
al., 2012) 
 80 (5)c ND 2010 Ireland PCR ND (Jahns et al., 
2010) 
 ND 22 (51) 2007–2010 Estonia PCR ND (Leimann et 
al., 2015) 
 1–5 (3 000 
000) 
ND 1999–2005 Canada CIEP ND (Farid et al., 
2012) 
Human 2/2b ND 1990s–
2000s 
Denmark CIEP, 
CCLAI, 
PCR, 
autopsy, 
HP 
Arteritis 
(1/2), 
glomerulo-
nephritis 
(1/2) 
(Jepsen et 
al., 2009) 
 7 (243) ND Late 1970s USA CIEP, CF ND (McGuire 
and 
Crawford, 
1980) 
 0 (18) ND 1970s USA CIEP ND (Bloom et 
al., 1975) 
a Number of tested individuals in parenthesis. 
b Number of positive individuals/number of individuals tested. 
c Number of tested farms. 
Abbreviations: Ab, antibody; AD, Aleutian disease; CIEP, counter-current immunoelectrophoresis; PCR, polymerase 
chain reaction; ELISA, enzyme-linked immunosorbent assay; HP, histopathology; ND, no data; ISH, in situ 
hybridization; IF, immunofluorescence; CCLAI, countercurrent line absorption immunoelectrophoresis; qPCR, real-time 
quantitative PCR; CF, complement fixation. 
2.6.2. Molecular epidemiology and phylogenetics 
Since the first report of AD over 60 years ago, details of the AMDV particle have been 
extensively studied. Initially, research mostly concentrated on a few well-documented 
AMDV strains of farmed mink identifying genetic markers for pathogenicity and other 
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biological features by sequence comparison and construction of molecular clones (see 
Chapter 2.3.1 for references). Originally, these strains were isolated from the pooled 
organs of many infected mink and have since been propagated in mink or cell culture for 
several generations (Bloom et al., 1975; Bloom et al., 1980; Hadlow et al., 1983; 
Alexandersen, 1986; Gottschalck et al., 1994). Thus, these strains do not necessarily 
represent the viral population in farms. 
The first phylogenetic analyses were performed in the 1990s and in the beginning of 
the 2000s (Gottschalck et al., 1994; Schuierer et al., 1997; Olofsson et al., 1999; 
Murakami et al., 2001). Sequence data and the applied phylogenetic methods were rather 
limited, but these first analyses suggested that the AMDV strains isolated from farmed 
mink can be divided into three major phylogenetic clusters (Olofsson et al., 1999). None 
of the studies indicated that AMDV strains would group based on the pathogenicity of the 
strain (Schuierer et al., 1997; Olofsson et al., 1999), country or region, or year of isolation 
(Schuierer et al., 1997).  
Common mechanisms of evolution applied by viruses are mutations, quasispecies 
formation, recombination, and reassortment (reviewed by MacLachlan and Dubovi, 2011). 
Data on AMDV evolutionary mechanisms are scarce. The virus seems to have a bias 
towards amino acid changes (Gottschalck et al., 1994; Schuierer et al., 1997; Olofsson et 
al., 1999) and it appears to be evolving under slight purifying or positive selection for 
variation with a dS/dN (dS, substitution rate at silent sites; dN, substitution rate at non-silent 
sites) ratio ranging between 0.29 and 1.26 (ratio >1, purifying selection; <1 positive 
selection) within different areas of the genome (Gottschalck et al., 1994; Schuierer et al., 
1997). However, the dS/dN ratio is relatively insensitive to the strength of natural selection 
when sequences from a single population or similar isolates are compared (Kryazhimskiy 
and Plotkin, 2008). Gottschalck et al. (1994), by including only a few strains, suggested 
that diversity in AMDV is the product of an ancient history rather than the result of a high 
mutation rate. They calculated that AMDV strains G and K have separated 700; and G and 
Utah 1 50 evolutionary years ago (calculated based on canine parvovirus capsid gene, 1.69 
× 10-4 /nt substitutions/year). Although many divergent strains exist, they seem to show 
high genomic stability exhibiting little evolution during six years of observation 
(Christensen et al., 2011). Recombination has been reported to occur in other parvoviruses 
(Lukashov and Goudsmit, 2001; Shackelton et al., 2007; Wang et al., 2012; da Costa et 
al., 2013). As AMDV induces a persistent infection with the potential for superinfections, 
there are good opportunities for recombination. Thus recombination may also occur in 
AMDV (Shackelton et al., 2007; Christensen et al., 2011), although further studies are 
needed. 
The phylogenetic and epidemiologic details of AMDV in farmed mink and free-
ranging mustelids in Finland have, prior to this study, largely been unknown. Finnish 
farmed mink strains have only been described in one earlier study; Olofsson (1999) 
included four strains from farmed Finnish mink in his study of AMDV strains in Sweden. 
This limited data set showed that the Finnish strains were closely related to Danish K 
strain and global Utah 1, SL3 and G strains of farmed mink. 
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3. Aims of the study 
The aims of this study were to: 
 
1. Develop AD diagnostics: to construct a new recombinant antigen with which 
to develop, automate, and validate a serological assay for detecting anti-
AMDV antibodies in blood samples of farmed mink and, in addition, to 
develop a simple blood sampling technique for the assay. (II, III) 
 
2. Evaluate the extent to which AMDV is present in free-ranging mustelids in 
Finland, estimate the prevalence, and elucidate any factors associated with 
AMDV infection. (IV) 
 
3.  Study the diversity, evolutionary relationships and infer the origin(s) of 
AMDV strains present in Finnish farmed mink and free-ranging mustelids, 
compare them to previously reported strains, and deduce possible 
correlations with their geographical and temporal distribution, transmission 
routes, pathogenicity, and the extent of their variation. (I, IV) 
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4. Materials and methods 
4.1. Study design and ethics 
Studies I and IV utilized cross-sectional designs and phylogenetic methods to study the 
molecular epidemiology of AMDV in Finnish free-ranging mustelids and/or farmed mink. 
Additionally, in study IV, analytical epidemiologic tools were used to estimate the 
prevalence, distribution, and potential risk factors for AMDV infection in Finnish free-
ranging mustelids. In studies II and III, cross-sectional designs were used to compare the 
results of two diagnostic tests (reference test, CIEP; index test, ELISA) in order to 
evaluate the performance of a newly constructed AMDV VP2 antigen and validate a new 
automated ELISA test based on this antigen and utilizing a new blood sampling method. 
The studies were carried out in Finland 2005–2014. 
The target population in studies I, II, and III was Finnish farmed mink and the source 
population was mink from farms sending their AMDV screening samples to Fin Furlab 
(formerly Fur Animal Feed Laboratory). The study sample was a convenience sample 
from mink on farms willing to participate in the studies. In study I, the sampled mink 
(serum, organs) were euthanized due to infertility, which was regarded as a sign of 
potential AD. Presampling with serological testing was not possible due to breeding 
season. Blood and serum samples in studies II and III were collected by STKL (T. 
Hinkkanen) during routine serological screening of AMDV. Although AD is not an OIE-
listed disease, the study (III) validating the automated ELISA test was designed following 
the OIE principles and methods of validation of diagnostic assays for infectious diseases 
(OIE, 2008). However, an evaluation of ELISA reproducibility could not be performed 
because the Fin Furlab was the only laboratory using this ELISA test at the time of the 
study. Results were reported according to the STAndards for the Reporting of Diagnostic 
accuracy studies (STARD) statement (Bossuyt et al., 2003) with minor modifications 
(Gardner et al., 2011). More information on the sampling framework, selection of animals 
and herds, and sampling protocol can be found in study III (Figure 1 and Methods). In 
studies II and III, the laboratory personnel were aware of the source farms identity. 
However, tests were either run simultaneously (III) or in a different laboratory (II), thus 
the personnel were unaware of the results from individual animals. 
In study IV, all mustelid species (both wild and feral) occurring throughout the country 
were targeted. Trapped animals and those that had died of natural causes were the source 
population. The sample population comprised animals obtained through our research 
partners (details in 4.2.1). Blood and organ samples were obtained from small game 
trappers during the hunting season or from carcasses sent to the Finnish Food Safety 
Authority (Evira) for necropsy. 
A license for animal experiment was not required for these studies (Act on the 
Protection of Animals Used for Scientific or Educational Purposes, 497/2013), as samples 
were collected either from euthanized, dead, or trapped animals or during routine 
serological screening. Protected species that are found dead can be delivered to a 
University for research purposes (Nature Conservation Act, 1096/1996; Hunting Act, 
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615/1993). All farms voluntarily participated in the studies and all samples were uniquely 
coded prior to being placed in storage. 
4.2. Sampling and sample storage 
4.2.1. Samples from farmed mink and free-ranging mustelids 
Blood samples were obtained by post-mortem cardiac puncture in blood-collection tubes 
(I), by toenail cutting in two 80 μl glass capillary tubes (II), or by collecting blood from 
the heart, wounds, peritoneal or thoracic cavity from a carcass on 2 × 7 cm filter paper 
(Tervakoski Oy, Tervakoski, Finland) strips (IV). The latter sampling procedure was also 
applied to Estonian free-ranging mustelids to obtain reference sequences for phylogenetic 
analysis (for more details see Leimann et al. (2015)). In study III, two blood samples were 
taken by toenail cutting from each animal, one into an 80 μl glass capillary tube and the 
other with a newly-developed sampling method; the filter paper blood comb (see more 
details in 4.8.2). Samples from the liver (I), mesenteric lymph node (I), and spleen (I, IV) 
were collected into cryo tubes after death. During post-mortem sampling, possible lesions 
related to AD were recorded (I), although a thorough necropsy was not conducted. Organ 
samples were stored prior to analysis at -70 °C (I, IV) or -20 °C (IV), blood combs and 
filter paper strips, after air-drying, at 4 °C (III, IV), room temperature (RT) (IV), or -20 °C 
(IV) and serum, after centrifugation, at 4 °C (III) or -20 °C (I, II). Detailed information on 
the sampling is presented in Table 4. The serum was analyzed for anti-AMDV antibodies 
by CIEP (I, II, III) and ELISA (II) and the filter paper and blood comb samples (III, IV) 
by ELISA. Background information on the sampling is provided in Table 4. 
The samples in study IV were collected through the Natural Resources Institute 
Finland (Luke) (formerly the Finnish Game and Fisheries Research Institute), the Finnish 
Food Safety Authority (Evira), and private small game trappers via Luke (formerly the 
Finnish Forest Research Institute), the Finnish Hunters’ Association, and the Finnish 
Wildlife Agency. The following data from the sampled animals were recorded for study I: 
farm location and identity, AMDV test prevalence, date, age, sex, genotype, clinical signs, 
and necropsy findings; study II: farm location and identity, AMDV test prevalence, and 
date; study III: farm location and identity, AMDV test prevalence, date, age, sex, 
genotype, vaccination status, and clinical signs; and for study IV: trapping/death location, 
date, species, gender, and age estimate (juvenile, adult).  
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Table 4. 
Background inform
ation on the sam
ples collected for studies I–IV 
Study Species 
N
 
Sam
ples 
Source A
dm
inistrative 
region 
A
M
D
V
 
prevalence Sym
ptom
s 
A
ge 
Sex G
enotype Tim
e 
M
ethod 
Purpose 
I 
Farm
ed A
m
erican m
ink 17
a 
O
rgans 
(spleen, 
liver, 
m
esenterial 
lym
ph 
node), 
serum
 
6 m
ink 
farm
s 
(A
–F) b  O
, N
O
 
10–91%
 
Infertility, 
anorexia, 
cachexia, 
loss of fur, 
epistaxis 
1–3 y 
1 ♂; 
16 
♀
 
15 non-
A
leutian;  
2 Aleutian 
Spring 
2005 
N
S1-
PC
R
, 
C
IEP 
M
olecular epidem
iology 
II 
Farm
ed A
m
erican m
ink 525 
Serum
 
3 m
ink 
farm
s; 
1, 2, 
and 3 
O
 
1: 0%
;  
2: >80%
; 
3: >80%
  
N
D
 
N
D
 
N
D
 
N
D
 
Sum
m
er 
2007 
C
IEP, 
m
anual 
ELISA
 
C
onstruction and 
evaluation of a new
 
antigen, developm
ent of 
an ELISA
 test 
III 
Farm
ed A
m
erican m
ink 761
c 
Serum
, 
blood 
2 m
ink 
farm
s; 
1 and 
2. 
C
O
 
1: 81%
;  
2: 2%
 
Farm
 1: 
history of 
clinical 
A
D
; farm
 
2: no 
history of 
clinical A
D
 1–4 y 
46 
♂
; 
715 
♀
 
N
on-
A
leutian 
Spring 
2008 
C
IEP, 
autom
ated 
ELISA
 
A
utom
ation and 
validation of the ELISA
 
test, developm
ent of a 
new
 blood sam
pling 
m
ethod 
IV
 
Feral A
m
erican m
ink, 
European pine m
arten, 
European badger, 
Eurasian otter, 
European polecat, least 
w
ease l, w
olverine, 
stoat 
308 
B
lood, 
spleen
d 
W
ild 
17/19 regions 
in Finland  
N
D
 
N
D
 
Juvenile-
adult e 
195 
♂
; 
110 
♀
f 
N
D
 
2006–
2014 
N
S1-
qPC
R
, 
m
anual 
ELISA
 
M
olecular and analytical 
epidem
iology  
a 2–3 sam
ples/farm
. 
b Farm
s D
, E, and F had recently encountered severe A
D
 outbreaks just after regaining A
M
D
V
-free status. 
c Farm
 1, 361 sam
ples; farm
 2, 400 sam
ples. 
d Spleen sam
ples w
ere obtained from
 263 anim
als. 
e A
ge w
as recorded from
 186 anim
als. 
f Sex w
as recorded from
 305 anim
als. 
A
bbreviations: A
M
D
V
, A
leutian m
ink disease virus; N
S1, non-structural protein 1; PC
R, polym
erase chain reaction; C
IEP, counter-current im
m
unoelectrophoresis; ELISA
, enzym
e-linked im
m
unosorbent assay; 
qPC
R
, real-tim
e quantitative PC
R; O
, O
strobothnia; N
O
, N
orth O
strobothnia; C
O
, C
entral O
strobothnia; N
D
, no data.  
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4.2.2. Sample size calculations (III, IV) 
The sample size to estimate diagnostic sensitivity (DSe) and specificity (DSp) in the 
automated ELISA validation study (III), was calculated with the following formula: ? ?
?
????? ?? ?
?
??? ? ??, where z1-α/2 = 1.96, α = 0.05, θ is the estimate of DSe or DSp, and e 
is the desired error margin on the estimate (Greiner and Gardner, 2000). Conservative 
estimates of 90% of ELISA DSe and DSp (previous estimates have been at least 97% for 
both (II, Andersson and Wallgren, 2013) were used with 5% allowable error, 95% 
confidence levels, and with assumption that each population would have 0% or 100% test 
prevalence. The appropriate sample size was 138. However, approximately 400 samples 
per population were targeted to account for test prevalence information from 2007 on the 
two study farms (Farm 1: high prevalence 81%; and farm 2: low prevalence 2%).  
The targeted sample sizes in the free-ranging mustelid study (IV) were 5–60 
individuals to detect disease in each species or area and 385 to estimate prevalence in the 
whole mustelid population. Sample sizes were calculated with EpiTools (Sergeant, 2013), 
and following parameter values were used for detecting disease: unknown population, 5–
50% prevalence, 99% test sensitivity, 95% population sensitivity; and for estimating 
prevalence: infinite population, 50% prevalence, 95% confidence level, and 5% error.  
4.3. Nucleic acid extraction (I, IV) 
DNA was isolated from 10 mg (IV) or 100 mg (I) of organ (I, IV) or blood (IV) sample. 
Organ samples were homogenized with a mortar and pestle (I) or lysed in a tissue lysis 
buffer (IV). Blood from filter paper (1 cm2) was eluted in 200 μl of phosphate buffered 
saline (PBS) (IV). DNA was extracted with TriPure (Roche, Indianapolis, USA) (I) or 
Qiagen DNeasy Blood & Tissue kit (Qiagen, Hilden, Germany) (IV). The DNA 
concentration was quantified by UV spectroscopy (NanoDrop 1000, Thermo Fisher 
Scientific, Pittsburgh, PA, USA), and the DNA was stored at -20 °C.  
In study I, DNA was extracted from all sampled animals and organs. In study IV, DNA 
was extracted from blood samples of 92/308 animals [all initially seropositive (n = 43), 
samples with S/P just below the cut-off (0.150–0.200, n = 3), and equal number (selected 
with simple random sampling without replacement) of seronegative samples (n = 46)] 
(more data on the cut-offs in 4.8.2). Spleen (IV), if available, was used only if the blood of 
a seropositive animal was negative in real-time quantitative PCR (qPCR). 
4.4. Amplification and detection of AMDV DNA by PCR (I, II, IV) 
For the molecular epidemiology study (I) in Finnish farmed mink, a part of AMDV NS1 
gene was amplified from the extracted DNA via a semi-nested PCR using previously 
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reported primers (Table 5). The reaction mixtures are shown in Table 6 and PCR 
conditions in Table 7. 
To construct the new antigen (II) to be used in serological assays, the complete AMDV 
VP2 gene was amplified prior to cloning with newly-designed primers from a Finnish 
farmed mink strain (FIN05/C8) described in study I. 
For detecting AMDV or closely-related amdoparvovirus DNA in free-ranging 
mustelids (IV) (as these potentially carry divergent strains), primers based on the recently 
described gray fox amdovirus (Li et al., 2011) and a qPCR protocol were developed. 
Fluorescence was measured at the end of the annealing step. A further segment to 
determine the dissociation curve of the PCR products was performed according to the 
manufacturer's protocol. Melting curve analysis was used to control the specificity of the 
products. Two runs were completed per sample and were regarded PCR positive when ≥10 
copies were amplified in both runs. If qPCR and ELISA gave discordant results, DNA 
isolation (from spleen if available), qPCR, and ELISA were repeated and the potential 
qPCR product was sequenced and verified to be AMDV DNA by a BLAST search 
(BLAST, 2014). 
A standard curve for viral quantitation (IV) for the qPCR was created by amplifying a 
part of the NS1 gene harboring the target sequence of the qPCR. After purification, the 
DNA concentration was quantified by UV spectroscopy (NanoDrop 1000, Thermo 
Scientific, Pittsburgh, PA, USA) and the copy number was calculated (Thermo Fisher 
Scientific, 2014). A standard curve was then created with seven ten-fold dilutions of the 
product ranging from 1:100 to 1:106. A threshold fluorescence level was calculated with 
MxPro qPCR software (Agilent Technologies, Santa Clara, CA, USA) using the 
individual threshold option. The correlation coefficient was 0.966, PCR amplification 
efficiency 81.6%, and detection limit ten copies. 
PCR reagents were supplied by Fermentas (Burlington, Canada) (I, II), Thermo 
Scientific (Pittsburgh, PA, USA) (IV), and Agilent Technologies (Santa Clara, CA, USA) 
(IV). The traditional PCRs were performed using PTC-200 Peltier Thermal Cycler (MJ 
Research, Waltham, USA) (I, II) and the qPCR by using Stratagene Mx3005P 
thermocycler (Agilent Technologies, Santa Clara, CA, USA) (IV). The PCR products 
were stained with ethidium bromide (I, II) or GelRed (Biotium, Inc., Hayward, CA, USA) 
(IV), run on 1% agarose gel (SeaKem LE Agarose, Lonza Group Ltd., Basel Switzerland 
or NuSieve Agarose, Cambrex BioScience Rockland Inc., Rockland, ME, USA) in 
tris(hydroxymethyl)aminomethane-borate-ethylenediaminetetraacetic acid (Tris-borate-
EDTA, TBE) (I, II) or Tris-acetate-EDTA (TAE) (IV) buffer, and after 30–45 min of 
electrophoresis at 80–85 V, were visualized under UV light.  
From each animal, one PCR product was purified from the reaction mixture with 
QIAquick PCR Purification kit (Qiagen, Hilden, Germany) (I) or treated with exonuclease 
I and thermosensitive alkaline phosphatase (Thermo Scientific, Pittsburgh, PA, USA) 
(IV). The products that were used for cloning (II) or creating a standard curve (IV), were 
purified from the gel with QIAquick gel extraction kit (Qiagen, Hilden, Germany). 
Contamination was avoided by using sterile filter-tips, protective clothing, detergent 
disinfectants, ultraviolet light, and unidirectional sample movement and negative controls 
were included in every PCR. Sample preparation, DNA extraction, PCR mix preparation, 
template pipetting, amplification, product purification, serological assays, and cloning 
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were performed in separate laboratories and two different facilities (the Faculty of 
Veterinary Medicine and the Faculty of Medicine, University of Helsinki). 
 
Table 5. PCR primers used for the amplification and detection of AMDV DNA 
Target gene Size, nt Positiona Forward primer Reverse primer Reference 
NS1 partial 
(I) 
390 563–952 5´-TTA GCT TTT 
GAC TCT ATT 
GAA GAG A-3´b  
5´-AAA ACT CAG 
CAA TTT CAT 
ATT CAC-3´c 
5´-TCG TTC TTT 
GTT AGT TAG 
GTT GTC-3´ 
(Olofsson 
et al., 1999) 
VP2 
complete (II) 
1944 2406–
4349 
5´-TTT GGA TCC 
AAT AGA GGA 
AAT GGA TTC 
TGC TG-3´d 
5´-TTT GAC GTC 
TTA GTA GAT 
ATA TTT GAT 
AGT GCT TCT 
TCC-3´e 
II 
NS1 partial 
(IV) 
641 1662–
2302 
5´-AAG ACT TTA 
AAG CCA TTA 
CTG GA-3´ 
5´-CTT TAG TTC 
CTC AGC ACT 
ATC C-3´ 
IV 
NS1 long 
(IV)f 
1725 578–2302 5´-CAT ATT CAC 
TGT TGC TTA 
GGT TA-3´ 
5´-CTT TAG TTC 
CTC AGC ACT 
ATC C-3´ 
IV; (Jensen 
et al., 2011) 
a Nucleotide position corresponding to the compete sequence of the AMDV-G strain (GenBank accession nos. M20036 
(I), NC_001662 (II), or JN040434 (IV)). 
b 1st round. 
c 2nd round. 
d BamHI digestion site underlined. 
e PstI digestion site underlined. 
f Used for creating the standard curve for qPCR. 
Abbreviations: PCR, polymerase chain reaction; AMDV, Aleutian mink disease virus; NS1, non-structural protein 1; 
VP2, structural protein 2; qPCR, real-time quantitative PCR.  
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Table 6. PCR reaction mixtures used in the amplification and detection of AMDV DNA 
Component Study I, NS1 
partial 
Study II, VP2 
complete 
Study IV, NS1 
partial 
Study IV, NS1 
long 
PCR Buffer with 
(NH4)2SO4 
1× 1×  1× 
Maxima SYBR 
Green Master 
Mix/ROX 
  1×  
dNTP mix 0.2 mM 0.2 mM  0.2 mM 
MgCl2 1.5 mM 1.5 mM  2 mM 
Forward and 
reverse primer 
0.5 μM 0.5 μM 0.6 μM 1 μM 
Taq polymerase 2.5 U 2.5 U  2.5 U 
Taq Extender    2.5 U 
Template DNA 1st round, 5 μl; 2nd 
round, 2 μl 
5 μl 5 μl 10 μl 
Molecular biology 
grade water 
To 100 μl To 100 μl To 25 μl To 100 μl 
Abbreviations: PCR, polymerase chain reaction; AMDV, Aleutian mink disease virus; NS1, non-structural protein 1; 
VP2, structural protein 2; dNTP, deoxynucleoside triphosphate. 
 
 
Table 7. PCR cycling conditions used in the amplification and detection of AMDV DNA 
Step Study I, NS1 
partial 
Study II, VP2 
complete 
Study IV, 
NS1 partial 
Study IV, 
NS1 long 
Initial denaturation 95 °C 10 min 95 °C 10 min 95 °C 10 min 94 °C 5 min  
Cycles 1st round, 34; 2nd 
round, 29 
1st round, 5; 2nd round, 
30 
40 40 
Denaturation 95 °C 30 s 95 °C 30 s 95 °C 30 s 95 °C 30 s 
Annealing 1st round, 56 °C; 2nd 
round, 54 °C 30 s 
1st round, 54 °C; 2nd 
round, 59 °C 30 s 
55 °C 1 min 55 °C 45 s 
Extension 72 °C 1 min 72 °C 1st round, 3 min; 
2nd round 2.5 min 
72 °C 1 min 72 °C 1.5 min 
Final Extension 72 °C 10 min 72 °C 10 min  72 °C 7 min 
Abbreviations: PCR, polymerase chain reaction; AMDV, Aleutian mink disease virus; NS1, non-structural protein 1; 
VP2, structural protein 2. 
4.5. Sequencing (I, II, IV) 
The purified PCR products (I, IV) and VP2-plasmid constructs (II) were sequenced with 
forward and reverse primers of the second round amplification (I), twice with the reverse 
primer (IV), or with commercial primers (M13, T7, and SP6) (II). Sequencing was 
performed with Biosystems Dye Terminator (v.3.1) sequencing kit and 3100 capillary 
sequence analyzer by the Sequencing Core Facility (Department of Virology, Faculty of 
Medicine, University of Helsinki). From each PCR product, two or three sequences were 
aligned and a consensus sequence was generated. 
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For the phylogenetic analyses in study I, one PCR-positive organ (usually spleen) per 
animal was sequenced (I). In study IV, up to three PCR-positive samples per region were 
sequenced favoring other species than mink (a total of 20/34 positives were sequenced). 
4.6. Sequence analysis (I, IV) 
The acquired nucleotide sequences were assembled and translated with BioEdit 7.0.5 
(Hall, 1999) (available at www.mbio.ncsu.edu/bioedit/bioedit.html) (I, IV) and GeneDoc 
2.6.0.2 (Nicholas and Nicholas, 1997) (I). Available reference sequences were collected 
from the GenBank database (GenBank, 2008; 2014). In study IV, additional reference 
sequences were obtained from Estonian free-ranging mustelids (Leimann et al., 2015), 
Finnish farmed mink acquired through diagnostic samples sent to the Department of 
Virology, and from study I. For more details of the sequences used see Appendix I. A 
species- and strain-demarcation criterion is currently lacking for amdoparvoviruses 
(Tijssen et al., 2011). In other genera of the Parvovirinae, strains that are <95% identical 
(i.e., >5% divergent) for the NS gene sequence are regarded as different species (Tijssen et 
al., 2011). Here, each unique sequence obtained was defined as a strain. 
Identity matrices of nucleotide and amino acid sequences were constructed with 
BioEdit 7.0.5 (Hall, 1999). The rates of synonymous (dS) and non-synonymous (dN) 
nucleotide substitutions were calculated with SNAP (Korber, 2000) (available at 
www.hiv.lanl.gov) using the Nei and Gojobori (1986) method (I).  
A multiple sequence alignment was assembled with ClustalW 1.83 (Thompson et al., 
1994) using default values. The phylogenetic analyses of study I were carried out with 
MEGA 3.1 (Kumar et al., 2004) using the maximum parsimony (MP) method with 
heuristic close-neighbor interchange search and PAUP* 4.0 (Swofford, 2003) with the 
maximum likelihood (ML) method. An appropriate model for ML, general time reversible 
+ invariant sites + gamma (GTR + I + G), was determined with the Modeltest 3.7 (Posada 
and Crandall, 1998) run in PAUP* 4.0. In study IV, the ML method with MEGA5 
(Tamura et al., 2011) and Bayesian method with BEAST 2 (Bouckaert et al., 2014) and a 
GTR model were used. Bootstrap resampling (1 000 pseudoreplicates) was performed to 
evaluate support for phylogenetic trees. Human parvovirus B19 (GenBank accession 
number (acc. no.) AY903437) and porcine parvovirus (acc. no. DQ499631) (I), or gray 
fox amdovirus (acc. no. JN202450) (IV) were used as outgroups. 
Recombination (I) between different groups of strains was analyzed with SplitsTree4 
(Huson and Bryant, 2006) using the HKY85 method (Hasegawa et al., 1985). Rate 
homogeneity (i.e., a molecular clock) (I) was tested with TreePuzzle (Schmidt et al., 2002) 
using ML (GTR model) and 25 000 puzzling steps. Rate heterogeneity with a uniform rate 
of nucleotide substitutions, gamma distribution with eight rate categories, and mixed 
model (1 invariable + 8 gamma rates) was used. 
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4.7. Recombinant VP2 antigen (II) 
4.7.1. Construction and expression 
The purified VP2 PCR product was ligated to pGEM-T plasmid (Promega, Madison, WI, 
USA) and transformed into Escherichia coli JM109 competent cells (Promega, Madison, 
WI, USA) according to the manufacturer's instructions. Bacteria were grown in Luria 
broth (LB) for 1 h in a shaker. For blue/white screening, the bacteria were plated on LB 
agar plates containing ampicillin (250 μg/ml), isopropyl-β-D-thiogalactopyranoside, and 
5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside (IPTG and X-Gal) and incubated 
overnight (o/n) at 37 °C. White bacterial colonies were suspended in LB containing 
ampicillin (100 μg/ml) and incubated o/n at 37 °C. Plasmid DNA containing the VP2 
insert was isolated with QIAprep Spin miniprep kit (Qiagen, Hilden, Germany) from the 
bacterial culture and digested with restriction enzymes BamHI and PstI (New England 
Biolabs, Ipswich, MA, USA) along with the baculovirus transfer plasmid pAcYML1 
(provided by Johan Peränen, Institute of Biotechnology, University of Helsinki; the 
plasmid was modified from Matsuura et al. (1987)). The VP2 insert and pAcYML1 
plasmid were run on an agarose gel, purified (QIAquick gel extraction kit, Qiagen, Hilden, 
Germany), ligated (T4 DNA ligase, New England Biolabs, Ipswich, MA, USA), 
transformed into Escherichia coli and grown as described above. Plasmid constructs were 
isolated from the bacterial suspension with EndoFree plasmid maxikit (Qiagen, Hilden, 
Germany).  
The purified plasmid DNA (2 μg) and baculovirus DNA (250 ng) (BaculoGold, 
Pharmingen, San Diego, CA, USA) were combined in transfection buffer containing 
FuGENE (Roche Diagnostics, Indianapolis, IN, USA) and Sf-900 medium (Gibco, 
Paisley, United Kingdom). The transfection medium was applied to Spodoptera 
frugiperda 9 (Sf9) cells (ATCC CRL-1711; American Type Culture Collection, Rockville, 
MD, USA) (3 × 106 cells per 25-cm2 flask) for 2 h at RT and 1 h at 27 °C. The transfection 
medium was discarded and the cells were grown in fresh Sf-900 medium supplemented 
with 10% fetal calf serum (Gibco, Paisley, United Kingdom), 1 × glutamine-penicillin-
streptomycin (Haartbio, Helsinki, Finland), and 0.25 mg/ml Fungizone (Bristol-Myers 
Squibb, Rueil-Malmaison, France) at 27 °C for four days. The cells and supernatant were 
separated by centrifugation (1 300 g for 5 min) and the cell paste was washed four times 
with phosphate-buffered saline (PBS) containing protease inhibitor (Roche Diagnostics, 
Indianapolis, IN). Subsequently, the cell paste was stored at -70 °C until processed to be 
used as an antigen and the supernatant was stored at 4 °C and used for subsequent 
infections.  
Once verified that the recombinant baculovirus produced antigen detectable by anti-
AMDV antibodies and after reaching a multiplicity of infection (MOI) of >1 after several 
subsequent passages, 1 ml of the supernatant was used for Sf9 cells in 25-cm2, 2 ml for 
50-cm2, and 4 ml for 75-cm2 flasks. The cells were incubated for 48 h to 72 h, until a 
cytopathic effect (CPE) was seen.  
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4.7.2. Extraction and purification 
A previously described method (Sico et al., 2002) with tris buffer (20 mM, pH 9) and 
heating was used to extract and purify the recombinant VP2 protein from the Sf9 cell 
paste. The method was applied with the following modifications: the cell paste was 
sonicated with 400 W for 4 × 5 sec pulses in 2 ml tubes, heated at 50 °C for 20 min, and 
centrifuged at 16 000 g for 30 min. The supernatant was then used as an antigen to 
establish recombinant VP2 CIEP and ELISA. To be used in CIEP, the recombinant 
antigen was first diluted 1:16 in PBS containing 0.05% bovine serum albumin (BSA) 
(Sigma-Aldrich, Steinheim, Germany) and 50 g/ml bromophenol blue (Merck Chemicals, 
Darmstadt, Germany). 
4.8. Serological methods 
4.8.1. CIEP (I, II, III) 
Anti-AMDV antibodies were measured from the serum samples by CIEP in Fin Furlab 
(formerly Fur Animal Feed Laboratory) (Vaasa, Finland). CIEP was performed using a 
commercially available (I, II, III) (Danad, Antigen Laboratory of the Research Foundation 
of the Danish Fur Breeders’ Association, Glostrup, Denmark) or newly developed 
recombinant VP2 (II) antigen. Counter-current immunoelectrophoresis was performed 
according to the manufacturer’s (Danad) instructions and results were visually inspected 
and interpreted by Majvor Eerola, Pia Söderback, and Mervi Houtsanen (Fin Furlab, 
Vaasa, Finland), each with several years of experience using the assay. Results were 
recorded as positive, negative, or unclear negative/positive. 
In studies II and III, CIEP was used as a reference standard (although an imperfect 
one) as it was the only test that was commercially available and it had been used for 
decades for large-scale screening of anti-AMDV antibodies in mink. In study II, CIEP 
with the commercial antigen was tested against CIEP (n = 209) and manual ELISA (n = 
316) utilizing the recombinant VP2 antigen. In study III, the performance of CIEP with 
the commercial antigen was compared to the automated AMDV VP2 ELISA using blood 
comb sampling. 
4.8.2. ELISA (II, III, IV) 
A simple and fast indirect ELISA method was developed for automated screening for anti-
AMDV antibodies in serum and filter paper blood samples. Optimal dilutions of the 
reagents were verified with chessboard titrations. In studies II and IV, the ELISA test was 
run manually, but in study III, the test was automated. The ELISA procedure is depicted in 
Figure 2. All ELISA procedures were done on either Nunc (II, III) (Finnzymes, Espoo, 
Finland) or Costar (IV) (Corning Inc., Corning, NY, USA) 96-well immunoplates, using 
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100-μl reagent volumes. A dilution buffer consisting of PBS with 0.05% Tween 20 and 
0.5% BSA was used in all serum and reagent dilutions (except the antigen).  
In the validation study (III), the ELISA method was applied with some modifications 
to suit for automation and robotics (see below). The blood combs, a new blood sampling 
method utilized in this study, were placed on the ELISA plate containing 100 μl of 
dilution buffer and soaked for 2 min. Thereafter the blood combs were discarded and the 
plate was incubated at RT for 1 h. 
In the free-ranging mustelid study (IV), the ELISA test was performed with the 
following modifications. One cm2 of filter paper saturated with blood was eluted overnight 
at 4 °C in one ml of PBS after which the filter paper was discarded. The eluted sample was 
diluted 1:10 in dilution buffer and 100 μl was pipetted in duplicate to an ELISA plate. The 
ELISA procedure was optimized for the new sample material with chessboard titrations 
with the antigen and conjugate.  
Results were expressed either as net OD values (mean OD for two blank wells was 
subtracted from the raw OD value) (II, III) or as sample to positive control (S/P) ratio 
[(mean sample optical density [OD] – mean blank well OD) ÷ (mean positive control OD 
– mean blank well OD)] (IV). 
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Figure 2. The ELISA procedure used for AMDV VP2 ELISAs in studies II, III, and IV. 
Abbreviations: VP2, structural protein 2; RT, room temperature; BSA, bovine serum albumin; PBS-T, PBS 
containing 0.05% Tween 20; HRP, horseradish peroxidase; IgG, immunoglobulin G; TMB, 3,3',5,5'-tetramethyl 
benzidine; ELISA, enzyme-linked immunosorbent assay; AMDV, Aleutian mink disease virus. 
Conjugate
•Diluted (1:4 500–1:8 000) HRP-
conjugated goat anti-cat IgG
• Incubation RT, 1 h
Coating
•Diluted (1:800–1:2 500) recombinant VP2 
antigen in 50 mM NaHCO3 buffer (pH 9.6) 
• Incubation RT, overnight
Wash
• 2 × with PBS-T
Blocking
• 1% BSA in PBS
• Incubation RT, 1 h
Samples
•Diluted (1:200) serum samples in duplicate (II)
•Blood comb samples (III)
•Diluted (1:10) filter paper blood samples in 
duplicate (IV)
• Incubation RT, 1 h
Wash
• 2 × with PBS-T
Wash
• 2 × with PBS-T
Colour development
• TMB
• Incubation RT, 15 min
Stopping
• 0.5 M H2SO4
Reading
• 450 nm
•Multiscan EX spectrophotometer
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Cut-off (II, III, IV) 
Cut-offs for the ELISA tests were determined either by counting the mean OD value of the 
CIEP-negative samples plus one standard deviation (SD) (II) or by using receiver 
operating characteristics (ROC) curve analysis with EpiTools (Sergeant, 2013) (III, IV) 
and choosing a cut-off that gave maximal values for both DSe and DSp when compared to 
CIEP (III) or qPCR (IV) results. The cut-off in study II was 0.255, III 0.248, and IV 0.292. 
In study IV, a preliminary cut-off was first set at S/P 0.2 by visual inspection of the 
histogram of the S/P values of all samples and a proportion of these (see Chapter 4.3) were 
selected for qPCR. 
Blood combs (III) 
A new blood sampling method, the so-called ‘blood comb’, manufactured from filter 
paper (Tervakoski Oy, Tervakoski, Finland) was developed for collecting the blood 
samples from farmed mink (see Figure 5 in study III). Twelve samples can be taken with 
one comb that corresponds to a single row of the ELISA plate. To block the comb from 
absorbing the liquid in the wells, the upper part was coated with a thin lacquer. A specific 
device was manufactured by CNC-Tekniikka Oy (Vaasa, Finland) for introducing the 
blood combs to the ELISA plate (see Figure 6 in study III). 
Automation (III) 
The automated ELISA system was built with the following devices supplied by Thermo 
Labsystems (Vantaa, Finland): Cat X robot, Wellwash AC washer, three Multidrop 384 
dispensers, and Multiscan Ascent EX spectrophotometer. The system was programmed 
using Polara 2.3 software. The automated steps were as follows: coating with prediluted 
antigen, dispensing the dilution buffer for blood comb samples, prediluted conjugate, 
3,3',5,5'-tetramethylbenzidine (TMB), and stopping solution, washing, reading, raw data 
capture, categorizing, presenting, and storing the results. 
4.8.3. Western blot (II) 
The identity and antigenicity of the recombinant VP2 protein was confirmed with sodium 
dodecyl sulfate-polyacrylamide gel (SDS-PAGE) electrophoresis and Western blot 
analysis. The Sf9 cell pellet infected with the recombinant baculovirus (1:100), non-
infected Sf9 cell pellet (1:100), and the purified recombinant VP2 antigen (1:10) were 
diluted in reducing Laemmli sample buffer and heated for 5 min at 95 °C (Laemmli, 
1970). The samples were electrophoresed through a 10% SDS-PAGE gel. The proteins 
were visualized with Coomassie blue staining and transferred from the gel to a 
nitrocellulose membrane. TE (0.5 M Tris, 1.5 M sodium chloride, 0.05 M EDTA) buffer 
containing 0.05% Tween 20 and 1% non-fat milk powder was used for blocking the 
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membrane and serum and conjugate dilutions. The membrane was blocked o/n at 4 °C and 
incubated with pooled sera from AMDV-infected and non-infected mink (1:300 dilution) 
for 1 h at RT. The membrane was washed with TE buffer containing 0.05% Tween 20 and 
incubated with horseradish peroxidase-conjugated goat anti-cat IgG (1:5 000 dilution; 
Jackson ImmunoResearch, West Grove, PA, USA) for 1 h at RT. After the second wash, 
the antigen-antibody reaction was visualized with 3,3'-diaminobenzidine (DAB) (Sigma-
Aldrich, Steinheim, Germany) staining. 
4.9. Control samples 
4.9.1. CIEP (I, II, III) 
Positive and negative controls provided by the CIEP antigen manufacturer (Antigen 
Laboratory of the Research Foundation of the Danish Fur Breeders’ Association, Glostrup, 
Denmark) were included on each gel. 
4.9.2. PCR (I, II, IV) 
Control material for AMDV DNA detection included DNA extracted from naturally 
infected and AMDV-free farmed mink (I, II) and free-ranging mustelids (IV) obtained 
from studies I and IV. Samples were verified as infected or AMDV-free with CIEP, 
Western blot, and/or ELISA (II) and VP2- (Oie et al., 1996) and/or NS1-PCR (Olofsson et 
al., 1999). Control DNA was stored at -20 °C in small aliquots. Positive and negative 
controls were included in each PCR run. 
4.9.3. ELISA (II, III, IV) 
Control sera for the detection of anti-AMDV antibodies was obtained from naturally 
infected and AMDV-free farmed mink (II, III) or free-ranging mustelids (IV) obtained 
from studies I and IV. The samples were verified as infected or AMDV-free with CIEP 
and/or Western blot and VP2- (Oie et al., 1996) and/or NS1-PCR (Olofsson et al., 1999). 
Control sera were stored at -20 °C in small aliquots. Duplicates of positive, low-positive 
(II, IV), a negative control serum and blank wells (containing all reagents except blood or 
serum) were included on each plate. The following dilutions were used: negative 1:200, 
low positive 1:40 000, and positive 1:200 (II); negative 1:4 and positive 1:300 (III); 
negative 1:10, low positive 1:80, and positive 1:120 (IV). 
54 
 
4.10. Electron microscopy (II) 
The Sf9 cell pellet infected with recombinant baculovirus was stained with 2% 
tungstophosphoric acid (pH 6.0) and studied with a Jeol JEM-100 CXII electron 
microscope (Advanced Microscopy Unit, Faculty of Medicine, University of Helsinki). 
4.11. Statistical methods (II, III, IV) 
Performance of the recombinant VP2 antigen and ELISA test (II) were assessed against 
the commercially-available CIEP test and validation of the automated ELISA test (III) was 
performed using several statistical methods (Table 8). A box-and-whisker plot of the 
ELISA results (III) was generated with EpiTools (Sergeant, 2013). 
In the free-ranging mustelid study (IV), statistical analyses were performed to evaluate 
the factors associated with infection. The outcome variable was infected (1) or AMDV-
free (0) and the animal was regarded infected if either ELISA or qPCR test or both were 
positive. The reason is that the animal might still be seropositive although it has cleared 
the virus, and the virus might be present but the antibodies are not yet detectable. Species, 
age (juvenile and adult), sex, year, and location (municipality and administrative region)6 
were independent variables. Due to a limited number of observations in some of the 
independent variables, they were regrouped as follows: species were divided into mink, 
badger, and other species; years when the samples were collected were separated into two 
categories, 2006–2009 and 2010–2014; municipalities were grouped into two categories, 
those that had no mink farms and those that had mink farms in the area during the 21st 
century; regions were handled as three different variables, region with two categories (the 
presence of no mink farms and mink farms in the region), with three categories (no farms, 
≤15 farms, and >15 farms in the region), and with 17 categories (total number of sampled 
regions). All location variables were analysed with separate models. Table 8 presents more 
data on the statistical methods used in each study. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
6 Finland is divided into 320 municipalities and 19 administrative regions. 
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Table 8. Statistical methods used in studies II, III, and IV 
Study Purpose Method/Program Details References 
II Diagnostic Se 
and Sp with 
95% CI 
Se=a/(a+c); Sp=d/(b+d)a; 
confidence limits for a 
proportion (Jeffreys 
interval), EpiTools. 
 (Brown et al., 
2001; 
Sergeant, 
2013) 
 Overall 
proportion 
agreement with 
95% CI 
(a+d)/(a+b+c+d)a; 
confidence limits for a 
proportion (Jeffreys 
interval), EpiTools. 
 (Brown et al., 
2001; 
Sergeant, 
2013) 
III Analytical Se End-point dilutions Six 10-fold dilutions ranging 
from 1:10 to 1:106 (two 
replicates/dilution) of the 
serumb were tested in both 
ELISA and CIEP. A dilution 
with positive results on both 
replicates was set as the 
detection limit. 
 
 Analytical Sp Cross-reactivity against 
other pathogens present in 
mink  
 
 
 
Ability to identify different 
AMDV strains  
Animals vaccinated against 
mink enteritis virus, 
Pseudomonas aeruginosa, and 
Clostridium botulinum were 
tested. 
 
Samples from different 
countries, regions and mustelid 
species (I, IV, and Knuuttila, 
2014 unpublished observations) 
were tested. 
 
 Overall, 
negative, and 
positive 
proportion 
agreement with 
95% CI 
Compare two tests and 
confidence limits for a 
proportion (Jeffreys 
interval), EpiTools 
 (Brown et al., 
2001; 
Sergeant, 
2013) 
 Kappa Compare two tests, 
EpiTools 
 (Sergeant, 
2013) 
 Diagnostic Se, 
Sp, and 
prevalences 
2-test 2-population 
Bayesian model, 
WinBUGS 1.4.3 
 
Conditional dependence, 
informative beta priors (study 
III, Table 4), 
non-informative (beta (1,1)) 
priors 
(Lunn et al., 
2000; 
Georgiadis et 
al., 2003; 
Branscum et 
al., 2005) 
 Model 
convergence 
Visual inspection of trace 
plots and running 3 chains 
from dispersed initial 
values, WinBUGS 1.4.3 
 (Lunn et al., 
2000) 
 Probability that 
ELISA DSe and 
DSp greater 
than CIEP DSe 
and DSp 
STEP function, WinBUGS 
1.4.3  
 (Lunn et al., 
2000) 
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Study Purpose Method/Program Details References 
 Predictive 
values 
PPV: the probability that 
an animal with a positive 
test result is truly positive; 
NPV: the probability that 
an animal with a negative 
test result is truly negative, 
WinBUGS 1.4.3. 
Informative beta priors on CIEP 
accuracy and prevalences (study 
III, Table 4) 
(Lunn et al., 
2000) 
 Within-run 
variability 
Variation in results of the 
replicates within the same 
run. CV% = SD ÷ mean × 
100%. 
Four replicates of each serumb 
on a single plate 
 
 Between-run 
variability 
Variation in results of the 
replicates between 
different runs. CV% = SD 
÷ mean × 100%. 
Duplicates of each serumb from 
20 runs on 5 different days 
 
 Within-serial 
repeatability 
variability 
Variation in results of the 
replicates between 
different reagent batches. 
CV% = SD ÷ mean × 
100%. 
Duplicates of each serumb 
against 3 different batches of 
antigen 
 
IV Prevalences 
with 95% CI 
Crosstabulation, SPSS 
Statistics version 21 and 
22; confidence limits for a 
proportion (Jeffreys 
interval), EpiTools. 
 IBM Corp., 
Armonk, NY, 
USA; (Brown 
et al., 2001; 
Sergeant, 
2013) 
 Pairwise 
associations 
Fischer's exact test and 
single variable logistic 
regressions, SPSS 
Statistics version 21 and 22 
Variables with P ≤0.2 included 
in multivariable logistic 
regression analysis and with 
Wald’s P <0.05 in the final 
model 
IBM Corp., 
Armonk, NY, 
USA 
 Correlation Spearman's test, SPSS 
Statistics version 21 and 22 
Variables with significant (P 
<0.05 and correlation 
coefficient >±0.2) correlation 
were not used in the same 
model. Correlation was found 
between species and 2 of the 
region variables (all regions and 
regions with farms vs. no 
farms). 
IBM Corp., 
Armonk, NY, 
USA 
 Confounders Causal diagram. Verifying 
the impact on the final 
model, SPSS Statistics 
version 21 and 22. 
 IBM Corp., 
Armonk, NY, 
USA 
 Risk factors Multivariable logistic 
regression, SPSS Statistics 
version 21 and 22 
 IBM Corp., 
Armonk, NY, 
USA 
 One-level 
interactions 
Verifying the impact on 
the final model, SPSS 
Statistics version 21 and 22 
 IBM Corp., 
Armonk, NY, 
USA 
 Goodness of fit Omnibus tests of model 
coefficients, Nagelkerke's 
R2, Hosmer and Lemeshow 
test, AUC. SPSS Statistics 
version 21 and 22. 
Good fit: Omnibus test, small P 
value; Nagelkerke’s R2, value 
close to 100%; Hosmer and 
Lemeshow test, large P value; 
AUC, value close to 1. 
IBM Corp., 
Armonk, NY, 
USA 
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Study Purpose Method/Program Details References 
 Outliers Studentized residuals, 
SPSS Statistics version 21 
and 22. 
Residuals >2.5 were verified IBM Corp., 
Armonk, NY, 
USA 
a a, true positive; b, false positive; c, false negative; d, true negative. 
b Positive control serum was used for the dilutions. 
c One negative and one low-positive mink serum was used, diluted and handled as the control sera (4.8.3). 
Abbreviations: Se, sensitivity; Sp, specificity; DSe, diagnostic sensitivity; DSp, diagnostic specificity; PPV, positive 
predictive value; NPV, negative predictive value; CV, coefficient of variation; SD, standard deviation; AUC, area under 
the curve; CI, confidence interval. 
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5. Results 
5.1. Development of a new diagnostic test 
5.1.1. Expression and evaluation of the recombinant VP2 protein (II) 
To develop a new antigen for the diagnostic test, the VP2 gene of a Finnish AMDV strain 
(FIN05/C8) was transferred to a baculovirus and the protein was expressed in Sf9 insect 
cells and purified. The VP2 gene was used as the protein forms empty capsids, or virus-
like particles (VLPs), that offer an optimal conformation for antigenic recognition. The 
presence and suitability of the recombinant VP2 antigen for serological assay was assessed 
with sequencing, electron microscopy, SDS-PAGE and Coomassie blue staining, Western 
blot, and by comparing the results of CIEP and ELISA performed with the recombinant 
antigen with the results of CIEP performed with the commercial antigen (consisting virus 
grown in cell culture).  
The sequence and reading frame of the insert were confirmed to be the AMDV VP2 
gene (1944 nt; 2406–4349) with a BLAST search (BLAST, 2008). The insert showed the 
highest nucleotide (98%) and amino acid (97%) identities with AMDV-G (acc. no. 
M20036) and -SL3 (acc. no. X97629). The VP2 sequence of this Finnish AMDV strain, 
FIN05/C8, was deposited in GenBank (acc. no. GQ336866). 
A protein band with the size of the AMDV VP2 protein (75 kDa) was identified with 
SDS-PAGE and Coomassie blue staining of the purified recombinant protein (Figure 1 in 
study II). Antigenicity was confirmed with a Western blot. Spontaneously-formed VLPs 
(23–25 nm in diameter) resembling parvovirus virions were observed under electron 
microscopy (Figure 3).  
 
 
 
Figure 3. Negative-stain electron micrograph of virus-like particles formed by the recombinant 
structural protein (VP2) of Aleutian mink disease virus. Modified from study II, Figure 2, reprinted 
with the permission from ASM. 
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The purified antigen was tested with conventional CIEP and the newly-developed 
ELISA method. Serum samples from 209 mink were analyzed by CIEP using both the 
recombinant and the commercial antigen. The cross-classified results with the 
recombinant antigen showed a DSe and DSp of 100% when compared to the commercial 
antigen (Table 9). Serum samples from 316 mink were analyzed with ELISA using the 
recombinant antigen and CIEP using the commercial antigen. When compared to CIEP, 
the ELISA results had a DSe of 99% and DSp of 97%. For the ELISA OD values, see 
Figure 3 in study II. 
 
Table 9. Cross-classified results for CIEP performed with commercial antigen compared 
with the results of  CIEP and ELISA performed with recombinant AMDV VP2 antigen 
  CIEP 
(commercial antigen) 
Overall 
proportion 
agreement% 
(95% CI) 
DSe% 
(95% CI) 
DSp%  
(95% CI) 
  Positive Negative Total    
ELISA 
(recombinant 
antigen) 
Positive 104 6 110 98.0  99.0  97.2  
Negative 1 205 206 (94.5–98.4) (95.6–99.9) (94.2–98.8) 
Total 105 211 316    
CIEP 
(recombinant 
antigen) 
Positive 100 0 100 100.0  100.0  100.0  
Negative 0 109 109 (98.8–100.0) (97.5–100.0) (97.7–100.0) 
Total 100 109 209    
Abbreviations: CIEP, counter-current immunoelectrophoresis; ELISA, enzyme-linked immunosorbent assay; AMDV, 
Aleutian mink disease virus; VP2, structural protein 2; DSe, diagnostic sensitivity; DSp, diagnostic specificity; CI, 
confidence interval. Modified from study II, reprinted with permission from ASM. 
5.1.2. Validation of the automated ELISA (III) 
The new ELISA method employing the recombinant VP2 antigen was automated and a 
new sampling method called ‘blood comb’ was developed. The new test was validated by 
comparing results with those of the CIEP test and according to OIE standards (OIE, 2008) 
including analytical, diagnostic and repeatability parameters. 
Performance metrics of the ELISA and CIEP tests were comparable (Table 10). Only a 
few discordant results were found, resulting in similar DSe and DSp. Six discordant 
results (3 ELISA positive/CIEP negative, and 3 ELISA negative/CIEP positive) were 
found in the high prevalence population and three in the low prevalence population 
(ELISA positive/CIEP negative). For the ELISA OD values, see Figure 2 (histograms) and 
Figure 3 (box-and-whisker plot) in study III.  
The median DSe of the ELISA test was 96.2% and DSp 98.4% according to a 
Bayesian analysis applying informative priors on CIEP test performance and prevalence 
(model 2) (Table 11 and study III, Table 3). The ELISA and CIEP had comparable 
accuracy in the two populations, as the probability that ELISA DSe and DSp were greater 
than the CIEP DSe and DSp were 58% and 55%, respectively. Results for models 1 and 3, 
modelling informative priors on a single parameter, were similar and verified the accuracy 
of the test. The dependence model was biologically and statistically more suitable for 
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Bayesian modelling as the conditional correlations (data not shown) between ELISA and 
CIEP results for models 1–3 were positive. Results of the other analyses included in the 
validation studies are given in Table 11. 
 
Table 10. Cross-classified results for CIEP and automated AMDV VP2 ELISA 
   CIEP  
  Positive Negative Total 
 Positive 343 6 349 
ELISA Negative 3 409 412 
 Total 346 415 761 
Abbreviations: CIEP, counter-current immunoelectrophoresis; AMDV, Aleutian mink disease virus; VP2, structural 
protein 2; ELISA, enzyme-linked immunosorbent assay. 
 
 
Table 11. Results of the validation analyses of the automated AMDV VP2 ELISA. 
Analysis Result 95% CI 95% PI 
Analytical sensitivity Detection limit: ELISA 1:10 000; CIEP 1:100 (for 
the titration curve, see Figure 4, study III) 
NA NA 
Analytical specificity No cross reactivity against mink enteritis virus, 
Pseudomonas aeruginosa, or Clostridium 
botulinum.  
Identified several Finnish, Swedish, and Estonian 
AMDV strains from different mustelid species (I, 
II, IV, Knuuttila, 2014 unpublished observations, 
Andersson and Wallgren, 2013). 
NA NA 
Diagnostic sensitivity 96.2% NA 91.5–99.0% 
Diagnostic specificity 98.4% NA 95.3–99.8% 
Kappa 0.976 0.961–0.992 NA 
Overall proportion 
agreement 
98.8% 97.9–99.4% NA 
Proportion positive 
agreement 
98.7% 97.7–99.8% NA 
Proportion negative 
agreement 
98.9% 97.0–99.4% NA 
Within-run 
variability 
Negative serum, CV 4% 
Low-positive serum, CV 8% 
NA NA 
Between-run 
variability 
Negative serum, CV 9% 
Low-positive serum, CV 26% 
NA NA 
Between serial 
repeatability 
Negative serum, CV 8% 
Low-positive serum, CV 6% 
NA NA 
Positive predictive 
value 
Farm 1, 99.9% 
Farm 2, 62.1% 
NA 99.7–99.99% 
6.5–69.0% 
Negative predictive 
value  
Farm 1, 61.2% 
Farm 2, 99.9% 
NA 17.8–90.0% 
99.6–99.99% 
Prevalences Farm 1, 94.3% 
Farm 2, 2.6% 
NA 90.3–98.4% 
0.3–5.4% 
Abbreviations: AMDV, Aleutian mink disease virus; VP2, structural protein 2; ELISA, enzyme-linked immunosorbent 
assay; CIEP, counter-current immunoelectrophoresis; CI, confidence interval; PI, probability interval; NA; not 
applicable; CV, coefficient of variation. 
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5.2. Epidemiology and phylogenetics of AMDV in Finland (I, IV) 
5.2.1. Serological and PCR results (I, IV) 
Farmed mink (I) 
To study the molecular epidemiology and construct phylogenetic trees of AMDV in 
Finnish farmed mink, organ and serum samples were collected from 17 animals from six 
farms. These samples were analyzed by CIEP for anti-AMDV antibodies and with NS1-
PCR for AMDV DNA. From the sampled mink, 13 were AMDV-antibody positive and 14 
AMDV-DNA positive. Three mink from farm A were negative. PCR results of each mink 
and organ are shown in Table 2 (study I). Some gross lesions typical for AD were detected 
in the positive mink, such as splenomegaly, mesenteric lympadenopathy, and discoloration 
and enlargement of the kidneys and liver. 
Free-ranging mustelids (II) 
Molecular and analytical tools were used to clarify the epidemiology of AMDV in free-
ranging mustelids in Finland. Samples were collected from 308 animals and analyzed with 
the new ELISA test for antibodies and with the new NS1-qPCR for DNA. Anti-AMDV 
antibodies were found in 35/308 and AMDV DNA in 34/92 mustelid samples (see Table 3 
in study IV). Nine discordant results were found, of which seven were from badgers (5 
ELISA positive/PCR negative, 2 ELISA negative/PCR positive) and two from mink 
(ELISA negative/PCR positive).  
Positive samples were detected in 3/8 species (see Figure 4 below and Table 1 in study 
IV). The prevalence was 54.4% in mink (31/57), 26.9% in badgers (7/26), and 7.1% in 
polecats (1/14). Pine martens (183), Eurasian otters (24), least weasels (2), wolverine (1), 
and stoat (1) had negative samples. Prevalence was higher in juveniles (19.2%) than in 
adults (10.2%), in females (13.6%) than in males (12.3%), and in years 2006–2009 
(21.1%) than in 2010–2014 (7.0%) (Table 12). The differences were statistically 
significant (P <0.05) in the species and year variables (Table 13 and Table 6 in study IV). 
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Figure 4. Number of AMDV-infected and -non-infected (tested by ELISA and/or qPCR) 
individuals in Finnish free-ranging mustelid species during 2006–2014. Abbreviations: AMDV, 
Aleutian mink disease virus; ELISA, enzyme-linked immunosorbent assay; qPCR, real-time quantitative 
polymerase chain reaction. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
63 
 
Table 12. Number and percentage of AMDV-infecteda mustelids per variableb 
Variable Infected/sampled % 95% CI 
Species    
American mink 31/57 54.4 41.5–66.8 
Badger 7/26 26.9 12.9–45.7 
Other species 1c/225 0.4 0.0–2.1 
Age    
Juvenile 15/78 19.2 11.7–29.0 
Adult 11/108 10.2 5.5–16.9 
Sex    
Male 24/195 12.3 8.3–17.5 
Female 15/110 13.6 8.2–21.0 
Year    
2006–2009 26/123 21.1 14.6–29.0 
2010–2014 13/185 7.0 4.0–11.4 
Municipalities, presence of mink farms    
No mink farms 33/283 11.7 8.3–15.8 
Mink farms 6/25 24.0 10.7–42.9 
Administrative regions, presence of 
mink farms 
   
No mink farms 14/64 21.9 13.1–33.1 
Mink farms 25/244 10.2 6.9–14.5 
Administrative regions, presence of 
mink farms 
   
No mink farms 14/64 21.9 13.1–33.1 
≤15 mink farms 16/196 8.2 4.9–12.6 
>15 mink farms 9/48 18.8 9.7–31.4 
a ELISA and/or qPCR positive.  
b All sampled regions (n = 17) were also included as a variable in the statistical analyses. Details are shown in Table 1 in 
study IV. 
c Polecat. 
Abbreviations: CI, confidence interval; AMDV, Aleutian mink disease virus; ELISA, enzyme-linked immunosorbent 
assay; qPCR, real-time quantitative polymerase chain reaction. Minor modifications from study IV. Reprinted with the 
permission from Society for General Microbiology (SGM). 
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Table 13. Multivariable logistic regression results of factors associated with AMDV 
infection in Finnish free-ranging mustelids during 2006–2014 
Factor B S.E. Wald’s 
P-value 
OR 95% CI 
Species      
Mink 5.81 1.06 0.00 334.59 41.98–2666.91 
Badger 4.30 1.11 0.00 73.61 8.40–644.78 
Other species 0.00 NA 0.00 1.00 NA 
Years      
2006–2009  1.66 0.50 0.00 5.28 1.97–14.13 
2010–2014 0.00 NA NA 1.00 NA 
Constant -6.36 1.07 0.00 0.00 NA 
Abbreviations: AMDV, Aleutian mink disease virus; B, logistic regression coefficient; S.E., standard error of each 
coefficient; OR, odds ratio; CI, confidence interval; NA, not applicable. 
Modified from study IV. Reprinted with the permission from SGM. 
5.2.2. Geographic distribution of AMDV in the wild (IV) 
Samples from free-ranging mustelids were obtained from 17 of the 19 administrative 
regions in Finland; no samples were available from Varsinais-Suomi or Åland (Figure 5). 
Positive samples were detected in 10 of the 17 sampled regions with a prevalence of 4.6–
50.0% (see Table 1 in study IV and Figure 5). Prevalence in free-ranging mustelids was 
highest (>20%) in Päijät-Häme, Pohjois-Savo, South Ostrobothnia, South Karelia, and 
Uusimaa. The AMDV prevalence was lower in those regions that had mink farms (8.2–
18.8%), in contrast to those regions that had no farms (21.9%) (Table 12). At the 
municipal scale, prevalence was higher in municipalities with mink farms (24.0%) than in 
those without (11.7%). The differences in the prevalence were statistically significant (P 
<0.05) in two comparisons; regions with mink farms versus no mink farms, and regions 
with less than 15 farms versus no mink farms (see Table 6 in study IV). 
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Figure 5. Prevalence of Aleutian mink disease virus in free-ranging mustelids and the number 
of mink farms per administrative region in Finland during 2006–2014. The size of the pie charts 
represents the total number of samples; black, percentage of positive American mink samples; yellow, percentage 
of positive polecat samples; red, percentage of positive badger samples; white, percentage of negative samples. 
Shading of the region represents the number of mink farms per region during the twenty-first century. 
Abbreviations: U, Uusimaa; VS, Varsinais-Suomi; S, Satakunta; KH, Kanta-Häme; PM, Pirkanmaa; PH, Päijät-
Häme; KL, Kymenlaakso; SK, South Karelia; ES, Etelä-Savo; PS, Pohjois-Savo; NK, North Karelia; CF, Central 
Finland; SO, South Ostrobothnia; O, Ostrobothnia; CO, Central Ostrobothnia; NO, North Ostrobothnia; K, Kainuu; 
L, Lapland; Å, Åland.© National Land Survey of Finland (NLS) 2014 (Contains data from the NLS municipal 
division database 6/2014). Minor modifications from study IV. Reprinted with the permission from SGM. 
5.2.3. Factors associated with AMDV infection in free-ranging mustelids (IV) 
In the multivariable logistic regression, species and year of sample collection were 
identified as factors being associated with infection with an odds ratio (OD) of 335 for 
mink and 74 for badger when compared to other species and 5 for the 2006–2009 
sampling period when compared to 2010–2014 (Table 13). Age, sex, location (region), or 
the presence of mink farms in the area (municipality, region) were not recognized as risk 
factors.  
U
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The final model was statistically significant and fitted the data well (Omnibus test of 
model coefficients, χ2 = 124.68, P <0.0005; Hosmer and Lemeshow test, χ2 = 0.341, P = 
0.843), accounting for 62.5% (Nagelkerke's R2) of variance in infection. The model 
classified 88.3% of cases correctly with a cut-off of 0.3. Sensitivity of the model to predict 
infection was 94.9%, specificity 87.4%, positive predictive value (PPV) 52.1%, and 
negative predictive value (NPV) 99.2%. The area under the curve (AUC) for the model 
was 0.947 (95% CI 0.921–0.974, P <0.0005). One outlier (studentized residual >2.5), the 
only infected polecat, was found and it was kept in the model. No confounders or one-
level interactions were found. 
5.2.4. Sequence analysis (I, IV) 
In study I, 14 new AMDV-NS1 sequences (343–377 nt in length) were obtained from 
Finnish farmed mink and deposited in GenBank (see Appendix I for accession numbers). 
Forty additional AMDV sequences, containing four previously-isolated Finnish strains 
(Olofsson et al., 1999), were obtained from GenBank and included in the analyses. Mean 
nucleotide sequence identities of all AMDV strains were 89% and amino acid identities 
83% (see Table 3 in study I and Table 14). When the sequences within each phylogenetic 
cluster (more data in the next Chapter) were compared, the variability was lower, being 
93–97% for nucleotide and 89–94% for amino acid data. The new Finnish strains had 86–
100% nucleotide and 78–100% amino acid identity to each other. The most divergent 
sequences of these new Finnish sequences (FIN05/D11–12 vs. FIN05/B4–6) had 86% 
nucleotide and 78% amino acid identity. Two sets of identical sequences were found 
(FIN05/B5 and FIN05/B6; FIN05/E14, FIN05/E15, and FIN05/F17). The mean dS/dN ratio 
was 2.71 (1.01–5.02), indicating a mild purifying selection (see Table 3 in study I). 
In study IV, 20 new NS1 sequences (401–439 nt in length) were obtained from Finnish 
free-ranging mustelids, including 17 feral mink, 2 badgers, and 1 polecat and representing 
9 administrative regions. Sequences were deposited in GenBank (see Appendix I for 
accession numbers). An additional 22 AMDV strains, representing Estonian free-ranging 
mustelids (4 badgers, 3 pine martens, 2 feral mink, 1 polecat) and 12 Finnish farmed mink 
were sequenced. Also, five global farmed mink strains were obtained from GenBank and 
included in the analyses. Nucleotide identities of all strains (both from farmed mink and 
free-ranging mustelids) ranged between 81% and 100% (Table 14). Identical sequences 
were found in Finnish farmed and feral mink and a badger (FIN14/L24 and FIN13/K22; 
Meme360_CF08 and Nevi358_CF08; Nevi456_U13 and Nevi458_U13). The most 
divergent sequences, with nucleotide identity of 81–86% to any other AMDV sequence, 
were found in four Estonian badgers. Initially, it seemed that sequences from free-ranging 
mustelids were more variable than those from farmed mink. However, the differences 
became trivial when the divergent sequences from badgers were excluded from the 
analysis.  
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Table 14. Mean sequence identitya of partial AMDV NS1 gene in farmed mink and free-
ranging mustelids 
Sequences from N Nucleotide 
identities 
Amino acid 
identities 
Reference 
All farmed mink 54 89% (81–100%) 83% (70–100%) I 
All farmed mink and free-ranging mustelids 47 91% (81–100%)  IV 
All farmed mink  17 93% (88–100%)  IV 
Finnish farmed mink 12 93% (88–100%)  IV 
All free-ranging mustelids 30 91% (82–100%)  IV 
Free-ranging mustelids, excluding divergent 
sequences from Estonian badgersa 
26 93% (88–100%)  IV 
Finnish free-ranging mustelids 20 94% (88–100%)  IV 
Estonian badgersb 4 97% (96–97%)  IV 
a Calculated by pairwise comparisons. 
b Meme125_EE07, 132_EE08, 133_EE08, and 134_EE08. 
Abbreviations: AMDV, Aleutian mink disease virus; NS1, non-structural protein 1. Modified from studies I and IV. 
Reprinted with the permission from Elsevier and SGM. 
5.2.5. Molecular epidemiology and phylogenetics of AMDV (I, IV) 
For AMDV strains in farmed mink the MP (see Figure 2 in study I) and ML (data not 
shown) methods recovered a similar tree topology. The AMDV strains formed three 
phylogenetic clusters or groups and, as no official genotyping system currently exists 
(ICTV, 2014), they were designated Groups I, II, and III. Finnish AMDV strains were 
present within each of them. The newly-sequenced Finnish AMDV strains resolved in 
Groups I and II. Group I was formed of strains from farm D, thus diverging from other 
Finnish strains found in this study, Swedish AMDV strains, and the highly pathogenic 
United strain from the USA. Strains from farms B, C, E and F shared a common ancestor 
with AMDV-G (USA), -SL3 (Germany), highly pathogenic -Utah 1 (USA), and two 
previously described Finnish strains (Olofsson et al., 1999) forming Group III. Group II 
only contained Nordic (Finnish, Danish, and Swedish) AMDV strains. The strains in 
Group III seemed to be more conserved with shorter branches than strains in the other 
clusters. Within the studied region, no recombination was detected between clusters (data 
not shown) and a clock-like substitution rate was rejected. 
In study IV, the ML (Figure 6) and Bayesian (data not shown) methods recovered 
similar tree topology for AMDV strains obtained from several mustelid species. The 
AMDV strains formed five phylogenetic clusters, with strains from free-ranging mustelids 
in each. Finnish AMDV strains could be found in 4/5 (I–IV), strains from farmed mink in 
4/5 (I–IV), and strains from free-ranging mustelids in 5/5 (I–V) groups. Group I of both 
studies (I and IV) and Group III of study I and Group II of study IV are equivalent and 
share the same strains. Strains from Finnish farmed mink were mainly found in Groups I 
and II (one strain in Group IV) and strains from Finnish feral mink in Groups I and III. 
Finnish strains from other mustelid species were resolved in three groups (I, III, and IV). 
In Groups I and IV, strains from free-ranging mustelids from Finland and Estonia shared a 
common ancestor with strains from Finnish farmed mink. AMDV strains from Estonian 
feral mink and Finnish farmed mink shared a common ancestor with global strains from 
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farmed mink in Group II.  Group III was formed by strains from Finnish and Estonian 
free-ranging mustelids and from strains from Chinese farmed mink. Most interestingly, 
Group V was formed solely by divergent Estonian badger AMDV strains (Figure 6). 
Although the virus was variable, it seemed to be evolving quite slowly, as strains isolated 
from Finnish farms up to nine years apart (Groups I and II), had not acquired new 
substitutions indicated by short terminal branches. Except for the divergent badger 
sequences and the tendency of strains from Finnish farmed and feral mink to diverge into 
separate clusters, no major factor linked to host species, location, isolation year, or 
pathogenicity could be detected in either study (I, IV). The phylogenetic analyses (I, IV) 
infer at least three introductions of AMDV into Finnish mink farms, as the Finnish strains 
currently circulating in farmed mink were resolved in three phylogenetic groups. 
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Figure 6. A phylogenetic tree of Aleutian mink disease virus (AMDV) sequences from 30 free-
ranging mustelids and 17 farmed mink based on an alignment of 373 nt fragment, including 
the end of the NS1 gene and part of the non-coding region, corresponding to nt 1854–2230 of 
the AMDV-G sequence (JN040434). The tree was reconstructed with a maximum-likelihood method and 
the numbers at nodes show bootstrap values (1000 pseudoreplicates, ?70% are not shown), and Bayesian posterior 
probabilities (right-hand values). Roman numerals indicate phylogenetic groups recognized in this study. The scale 
for genetic distance is provided. Known pathogenic strains are marked with an asterisk, feral mink strains with a 
black background, indigenous wild mustelid strains with a gray background, and farmed mink strains with a white 
background. Abbreviations: NS1, non-structural protein 1; nt, nucleotide. For strain abbreviations see Appendix I. 
Minor modifications from study IV. Reprinted with the permission from SGM. 
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6. Discussion 
6.1. Diagnostics (II, III) 
6.1.1. New recombinant VP2 antigen can be used both in CIEP and in ELISA 
(II) 
In this study (II), a recombinant AMDV VP2 antigen based on a Finnish field strain was 
engineered and used to develop an indirect IgG ELISA test. Results showed that the 
recombinant VP2 proteins were antigenic, formed VLPs, and could be used as an antigen 
both in a conventional CIEP test (DSe and DSp, 100%) as well as in the new ELISA test 
(DSe, 99%; DSp, 97%). 
Aleutian mink disease virus recombinant VP2 or VP1/VP2 proteins have been made 
previously (Clemens et al., 1992; Christensen et al., 1993; Wu et al., 1994; Costello et al., 
1999; Zeng et al., 2007), and have been shown to be antigenic and form VLPs (Clemens et 
al., 1992; Christensen et al., 1993; Wu et al., 1994). In spite of these early developments, 
diagnostic applications have been scarce (Clemens et al., 1992; Aasted et al., 1998; Zeng 
et al., 2007) and published data on their performance are limited. Clemens et al. (1992) 
showed that the recombinant VP1/VP2 antigen gave higher DSe and higher titers in CIEP 
than the cell-culture derived AMDV-G antigen (n = 10). Zeng et al. (2007) reported a DSe 
of 100% and DSp of 90.5% for CIEP performed with the recombinant VP2 antigen when 
compared to the cell-culture derived antigen (n = 54). We also attempted traditional 
propagation of the virus (Finnish strain FIN05/B4) in a cell culture, but replication failed 
after a few passages (Knuuttila, 2005 unpublished observations). Instead, expression of 
the recombinant protein in the baculovirus allowed for fast and easy production of large 
amounts of conformationally ideal antigen (VLPs). 
Several studies have described ELISA tests for detecting anti-AMDV antibodies in 
mink (Wright and Wilkie, 1982; Miroshnichenko et al., 1992; Aasted et al., 1998; Costello 
et al., 1999; Castelruiz et al., 2005), but until recently (see the next Chapter) these were 
mainly used for research instead of mass screening purposes. Data on the accuracy of the 
ELISA tests have also been scarce. In one study, results of ELISA and CIEP tests using an 
organ-derived whole virus antigen were compared and the authors concluded that the DSe 
of ELISA is rather low (Wright and Wilkie, 1982). In contrast, a later study found ELISA 
to be more sensitive than CIEP (Miroshnichenko et al., 1992). Although the CIEP and 
ELISA tests performed similarly in our study (II), a few discordant results were observed. 
One sample was determined to be negative by ELISA but positive by CIEP, whereas six 
samples were pronounced positive by ELISA but negative by CIEP. Several studies 
suggest that the ASe and/or DSe of CIEP is lower than that of other methods (Crawford et 
al., 1977; Aasted and Cohn, 1982; Alexandersen and Hau, 1985; Alexandersen et al., 
1985a; Aasted et al., 1986; Miroshnichenko et al., 1992; Farid et al., 2015). Thus, it is 
possible that at least some of the ELISA-positive but CIEP-negative samples were actually 
true positives, meaning that the ELISA would be more accurate than these results 
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suggested. This is further supported by the rather high ODs (0.6–1.2) of most (4/6) of the 
discordant samples (see study II, Figure 3). However, false positive results can be caused 
by a variety of reasons, for example cross-reactions, non-specific binding, differences in 
the antibody detection level and in the capability of antibodies to recognize different 
AMDV strains. Furthermore, differences in the structure of the antigen (CIEP, whole 
virus; ELISA, recombinant VP2) and in the propagation and purification methods may 
account for some discrepancies in the results.   
Due to the implementation of the eradication program in Finland in 2005, the number 
of tested samples rose from 330 000 in 2005 to nearly 800 000 in 2014 (M. Eerola [Fin 
Furlab], personal communication 21.5.2015). The anticipated rise in sample numbers 
created a need for a highly accurate, economical, and high-throughput assay, as CIEP test 
requires a large amount of labor and is not well-suited to automation. During development 
of the ELISA assay system, technical challenges emerged and dispensing several assay 
reagents had to be automated and a new system of collecting and transferring blood/serum 
samples to an ELISA plate had to be created. Results of this study (II) showed, however, 
that the traditional antigen can be replaced by the newly-developed recombinant antigen 
and encourages further development of the ELISA assay for mass screening of AMDV 
infection in mink.  
6.1.2. New automated ELISA test for the serodiagnosis of AMDV in mink (III) 
The new ELISA test based on the VP2 recombinant antigen and utilizing the new ‘blood 
comb’ sampling method was automated and validated (study III). The test was compared 
to conventional CIEP with cell culture antigen (Danad) and glass capillary sampling. The 
ELISA test was found to be highly sensitive (DSe 96.2%), specific (DSp 98.4%) and 
suitable for the large-scale serodiagnosis of AMDV infection in mink.  
Diagnostic tests used for the eradication and control of a disease should be reviewed 
and updated at regular intervals. If one test is used for an extended period of time, with 
decreasing prevalence the probability that false-positive animals will be culled increases. 
As the CIEP test has been in widespread use for several decades, an updated or new test 
for the serodiagnosis of AMDV was deemed necessary. Serological assays offer an 
appropriate technique for diagnosing AMDV infection in mink, as presumably the level of 
anti-AMDV antibodies is high in all infected adults even if they do not develop chronic 
disease symptoms (Bloom et al., 1994). In eradication programs in general, a screening 
test with a high DSe and ASe is needed to identify positive animals in early stages of 
infection so control measures can be taken to limit the disease spreading. However, if no 
confirmation test is used, the test should also have high DSp (and thus high PPV at low 
prevalence) to avoid false-positive results and excessive culling and costs to farmers (in 
the case of AMDV: loss of valuable breeding animals and group A status, and effects on 
mink trade). Our results show that the new automated ELISA test can be utilized for the 
control and eradication of AMDV, calculating seroprevalence, and confirming the 
infection status of farms and individual mink. The test was first implemented at Fin Furlab 
in 2008, and since that time the testing capacity has increased and the sample processing 
time has decreased. Furthermore, although capital investment was needed for new 
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equipment, testing costs are now lower due to decrease in labor cost. Moreover, the new 
ELISA system also allows automated plate reading and data management. In contrast, 
CIEP results must be read by a human operator and are thus subject to error before being 
recorded manually and stored in a paper format. 
The results of our study (III) on the DSe and DSp of the automated ELISA test are 
comparable to the findings of Andersson and Wallgren (2013) and our previous study (II). 
Farid and Segervall (2014) reported slightly lower DSe (91% and 94%) for our ELISA 
compared to CIEP, but their results fell within the 95% PI reported by us in study III. In 
our study (III), results of the Bayesian analysis showed that the DSe and DSp of ELISA 
and CIEP were not significantly different irrespective of the model used, and were 
comparable for both tests. Nine discordant results were found between ELISA and CIEP 
(Table 10). As in study II, most (6) of these were ELISA-positive but CIEP-negative. The 
possible causes of the discordance have been detailed in the previous chapter. This test, as 
far as is known, is the first automated ELISA method (in use since 2008) for the 
serodiagnosis of AMDV infection in mink. Recently, few other commercial ELISA tests 
have been developed. A Danish automated ELISA test, based on cell-culture derived 
AMDV-G antigen (ELISA Danad antigen, Kopenhagen Fur, Glostrup, Denmark) and 
dried blood spot cards, was shown to have a similar performance to CIEP with DSe of 
88.6% and DSp of 99.8% (Dam-Tuxen et al., 2014). In addition to this, an ELISA kit 
based on the cell-culture derived AMDV-G antigen (Scintilla Development Company 
LLC, Bath, PA, USA) is available. Andersson and Wallgren (2013) compared the results 
of this kit and the ELISA test developed by us to CIEP and concluded that our 
recombinant VP2-ELISA had higher DSe than the ELISA kit. They reported a DSe of 
99.7% and DSp of 98.3% for our ELISA when compared to CIEP. Additionally, an 
ELISA test is available for ferrets at the University of Georgia, USA 
(http://www.vet.uga.edu/idl/tests). 
The results suggested high ASe and ASp for ELISA. As in several previous studies of 
other test methods (Crawford et al., 1977; Aasted and Cohn, 1982; Alexandersen and Hau, 
1985; Alexandersen et al., 1985a; Aasted et al., 1986; Farid et al., 2015), our findings also 
infer that the ASe for CIEP is lower than that for ELISA. In general, the analytical 
sensitivity of ELISA test (approximate sensitivity <1 μg/dl) is higher than that of 
counterimmunoelectrophoresis (<0.1 mg/dl) (reviewed by Thrusfield, 2007b). However, 
for more reliable results of the ELISA ASe, additional samples, replicates, and dilutions 
should have been made and examined. Although the strains of AMDV are highly variable 
(study I and IV,  Gottschalck et al., 1994; Olofsson et al., 1999)  , this ELISA test was able 
to identify positive samples from mink infected with strains from different groups and 
countries as well as several species (studies I, II, and IV, Andersson and Wallgren, 2013, 
Knuuttila, 2014 unpublished observations). On the other hand, positive reactions caused 
by antibodies directed to other mink pathogens were not seen. 
In general, repeatability of the ELISA test was high with a CV less than 10%. One 
exception was the low-positive serum with a between-run CV of 26%. The higher 
variability of this sample was anticipated, as sera with values between the cut-off and 
high-positive value tend to vary more than the negative and high-positive samples. As this 
test is used qualitatively and not quantitatively, and none of the low-positive values were 
below the cut-off point, this was not regarded as a major problem. When further 
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developing this test platform, this issue can be taken into account by normalizing the 
results, for example, by expressing them as S/P-ratio (as in study IV) and by implementing 
an internal quality control system such as Levey-Jennings control charts or Westgard 
multirule system (Westgard, 2009). 
As expected, the PPV was high in the high prevalence population and the NPV for the 
low prevalence population. However, despite the rather high DSp, the PPV was only 
62.1% for the low prevalence population. This issue can be resolved by using 
confirmatory tests (i.e., serial testing) with a high DSp for those animals that test positive 
in the ELISA test, especially in AMDV-free and low prevalence farms. Primers and a 
qPCR protocol, described in study IV, are currently used for this purpose to confirm 
AMDV DNA positivity. A sample from the spleen is required for reliable diagnostic 
results (Jensen et al., 2011), as excretion in feces, saliva, and blood often appears to be 
intermittent and transient (Jensen et al., 2014; Farid et al., 2015). Anyhow, the duration of 
the excretion needs further research as the results might reflect the difference in ASe of 
the different PCR protocols. Optimally, the confirmatory test would not require the animal 
to be sacrificed. 
In Finland, the ELISA test is routinely used at Fin Furlab and the system is also used in 
the Netherlands. The recombinant VP2 antigen is commercially available and used for 
diagnostic purposes in Sweden and the Netherlands. The test may also be used to study the 
epidemiology of AMDV in mink and free-ranging mustelids. Efforts to produce a 
commercially-available ELISA kit based on this system are also under way (Poikulainen, 
2014). As the ELISA test also provides quantitative data, it might be possible to develop a 
classification scheme based on the results (Farid and Segervall, 2014). Animals with high 
OD values fall into different classes than animals with low OD values. This might help the 
farmer to cull mink that are more seriously affected. Further knowledge, however, is 
needed whether feasible antibody classes can be implemented and whether these classes 
actually interrelate with the severity of the disease. 
6.1.3. Filter-paper blood comb – a new sampling method for ELISA (III) 
A new sampling method, filter paper blood comb (see study III, Figure 5), was developed 
to replace the glass capillary tubes used in CIEP. Additionally, a specific device (see study 
III, Figure 6) was engineered to transfer samples on the blood combs to an ELISA plate. 
The device ensures rapid and precise handling and simultaneous elution of samples 
preventing variation in results caused by differences in the elution and incubation times. 
Guthrie and Susi (1963) first introduced the filter paper blood sampling for infants in the 
1960s. Since then, it has been applied in human and veterinary medicine (Mei et al., 2001; 
reviewed by Curry et al., 2011). However, in many of the ELISA tests employing filter 
paper sampling, an additional elution and dilution step of the blood samples is required. In 
our method, the comb can be directly introduced to the ELISA plate for the elution of 
antibodies, thus reducing the processing time. Blood comb sampling offers several 
advantages: the required blood sample is small and collection is simple and rapid; samples 
do not get mixed, lost, or damaged; they are easy to code, ship, and store, and the 
centrifugation step required by capillary tubes systems is not needed. Blood combs also 
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make it possible to pool several samples into a single well. This testing scheme is 
particularly suitable for the monitoring of AMDV-free farms, reducing costs and allowing 
for rapid and more frequent testing. 
6.2. Epidemiology and phylogenetics of AMDV in Finland (I, IV) 
6.2.1. Several introductions into Finnish farms (I, IV) 
Based on the tree topology, the AMDV strains formed five genetic groups, of which 
strains from farmed mink were present in four. However, the fifth group, due to its 
divergence, possibly represents a new and currently undescribed species (Figure 6). 
Previous studies have reported three to six phylogenetic groups for AMDV (Olofsson et 
al., 1999; Jensen et al., 2012; Sang et al., 2012; Nituch et al., 2012; Leimann et al., 2015). 
It appears that AMDV has been introduced into Finnish farms on several occasions. At 
least three introductions have occurred, as strains from Finnish farmed mink could be 
found in three phylogenetic clusters. A fourth introduction is also possible, as closely 
related strains were found in Finnish free-ranging mustelids and Chinese farmed mink 
(Group III, study IV), suggesting a common ancestor in Finnish farmed mink. But this 
lineage might have disappeared from farms (e.g., due to eradication efforts) or was not 
found due to a limited number of samples.  
The variability of Finnish strains suggests that the origins of the Finnish virus strains 
are in several sources. Unfortunately, the exact origin of the Finnish strains (both at farms 
and in the wild) remains to be clarified due to a lack of data on the animal trade and the 
limited number of available sequences from exporting countries and wild mustelids 
elsewhere. Some inferences can, however, be made. As Finnish strains shared ancestors 
with strains from farmed mink from several different countries (the USA, Denmark, 
Sweden, China, Estonia, and Germany), it may be hypothesized that the virus has been 
introduced into Finnish farms through the global mink trade. It is known that the first 
mink were imported from the USA during the 1930s and subsequently from Denmark and 
Sweden in the 1940s. Thus, the Finnish strains in Groups III (study I) and II (study IV), 
containing two strains from the USA, may be of North American origin. The ancestors of 
Groups I (study I and IV) and II (study I) might originate from other Nordic countries as 
these included several sequences from Sweden and one from Denmark. Fewer data are 
available from Groups III and IV (study IV). Subsequently, the virus may have spread into 
the wild either from infected escaped/released mink from Finnish farms and at the Russian 
border or from the premises of infected farms accessed by wild animals. Alternatively, it 
might also have been present in wild mustelids before mink farming began. Wild 
mustelids may also carry their own divergent strains, potentially new amdoparvoviruses, 
as observed in Estonian badgers. In summary, the majority of the Finnish AMDV strains 
are closely related to other European and North American AMDV strains and strains of 
various genotypes are present in Finland. The situation is different in Denmark where the 
virus population seems to be more homogenous, which is probably due to long lasting 
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eradication efforts that have been in place since 1976 (Christensen et al., 2011). Also, the 
origin of the common ancestor of all AMDV strains needs further study. Due to historic 
reasons (e.g., North American origin of mink and the first appearance of the disease) it 
may be hypothesized that AMDV has been transmitted from North America to the other 
mink-producing countries, although this may be too simplistic (Farid, 2013). Instead of 
mink, origin of AMDV in another mustelid species is also possible.  
In our studies, a partial NS1 gene was analyzed and more sequence data (both larger 
number and longer sequences) are needed to further elucidate the evolutionary history and 
relationships of this virus on a global scale. In particular, it would be interesting to study 
the presence of AMDV or related amdoparvoviruses in farmed mink, ferrets, and wild 
mustelid species in other countries and especially those with no history of mink farming. 
In study I, we used the same partial NS1 gene as Olofsson et al. (1999) to include as many 
reference sequences as possible. At the time, the amount of AMDV sequence data in 
GenBank was very limited. The initial plan in study IV was to use both partial NS1 and 
partial VP2 (Oie et al., (1996), as at the time many reference sequences were available for 
mink, less so for other mustelids. However, we soon noticed that these protocols failed to 
identify all AMDV strains and a new qPCR protocol with new primers was applied (see 
Chapter 6.2.5.). Unfortunately, a disadvantage met with in doing this was the restricted 
number of global reference sequences. As our focus also included the analytical 
epidemiology, we sought to sequence as many infected individuals as possible.  
Phylogenetic trees recovered in our studies included several new field strains with 
nucleotide data and discrete phylogenetic methods. We aimed to use the most 
sophisticated phylogenetic methods available and to take all codon positions into account 
to analyze the evolutionary differences more sensitively. The resolution of previously-
described strains (United, K, SL3, Utah 1, G, and Finnish and Swedish strains in Olofsson 
et al. (1999)) was similar to what has been presented earlier (Gottschalck et al., 1994; 
Schuierer et al., 1997; Olofsson et al., 1999). Also, the grouping of strains from farms B, 
C, D, and F, shared by both studies, was comparable.  
Although the focus of these studies was to infer the molecular epidemiology and 
evolutionary relationships of Finnish AMDV strains, results provided additional insights. 
Building on Oloffson et al. (1999), study I represents one of the first studies of the 
molecular epidemiology of AMDV and contained many more sequences than previous 
works. Since then, the extent of phylogenetic research of AMDV has developed hand-in-
hand with advances in molecular techniques and phylogenetic and statistical methods of 
analysis. Thus, in the last five years, a growing number of sequences exists for feral and 
wild mink and the number of studies elucidating the molecular epidemiology of the virus 
has increased (Christensen et al., 2011; Jensen et al., 2012; Nituch et al., 2012; Sang et al., 
2012; Leimann et al., 2015; Nituch et al., 2015). However, study IV was the first 
description of the molecular epidemiology of this virus in mustelids other than mink and 
ferret. The new sequence data obtained and detection methods developed for these studies 
enable further research on the epidemiology and evolutionary relationships of AMDV and 
related viruses as well as outbreak investigations at farms. Additionally, the qPCR can be 
used as a confirmatory test. 
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6.2.2. Strains show high variability (I, IV) 
Based on the partial NS1 sequence, the Finnish AMDV strains from farmed mink showed 
divergence of up to 14% at the nucleotide and 22% at the amino acid level, whereas the 
strains from free-ranging mustelids showed divergence of up to 12% at the nucleotide 
level. Identical sequences were identified both in the farmed mink within the same and 
from different farms and between feral mink and a badger. The overall variability of all 
AMDV strains was up to 19% at the nucleotide and 30% at the amino acid level, and 
similar to what has been reported previously for the NS1 region (Olofsson et al., 1999; 
Nituch et al., 2012). The most divergent mink strains were the Swedish strains D1S and 
N2S reported by Olofsson et al. (1999). The strains in these studies were quite similar 
within one farm, but strains from one farm can fall into different phylogenetic groups 
(Olofsson et al., 1999) and even one animal may be simultaneously infected with several 
types of strains (Gottschalck et al., 1991). 
Although the virus was variable, it seemed to be evolving quite slowly, as strains that 
were isolated for several decades (Utah 1, 1960s; G, 1970s; K and SL3, 1980s) have failed 
to acquire many new mutations during that time. Similarly, strains from Finnish farms 
isolated for up to nine years remain unchanged (study IV, Groups I and II). Similar results 
concerning strain stability have been reported by Christensen et al. (2011), and 
Gottschalck et al. (1994) concluded that AMDV is an old virus based on retained 
nucleotide sequence substitution rate of canine parvovirus. However, study I rejected a 
molecular clock which provides no evidence for a general and linear evolutionary rate in 
AMDV. This makes it difficult to infer the age of the virus and place its diversification 
within an absolute timescale. Given that DNA viruses such as AMDV replicate in the 
nucleus and are subject to host-cell proofreading, they probably have mutation rates 
similar to that of host-cell DNA (reviewed by MacLachlan and Dubovi, 2011). Based on 
the NS1 sequence, AMDV appeared to be under mild purifying selection (mean dS/dN = 
2.71). Mild purifying or neutral selection for AMDV NS1 has also been reported by others 
(Gottschalck et al., 1994; Lukashov and Goudsmit, 2001; Christensen et al., 2011), and the 
dS/dN ratio reported here is within the range known for other parvoviruses, i.e., 1 to 22.5 
(Lukashov and Goudsmit, 2001). 
Although it is known to occur in parvoviruses (Lukashov and Goudsmit, 2001; 
Shackelton et al., 2007; Wang et al., 2012; da Costa et al., 2013), recombination was not 
detected in our study (I), possibly due to the relatively short length of sequence studied. 
Although data are lacking, AMDV offers good opportunities for recombination (chronic 
infection, potential superinfections) and some authors suggest that it is likely (Shackelton 
et al., 2007; Christensen et al., 2011). 
6.2.3. Potential novel amdoparvovirus in Estonian badgers (IV) 
A highly divergent strain was discovered in Estonian badgers showing only 81% to 86% 
nt similarity to any other AMDV sequence based on the partial NS1 gene and formed a 
sister group to other AMDV strains (Figure 6). It is possible that these Estonian strains 
represent a novel amdoparvovirus species, a ‘badger amdoparvovirus’. Further support for 
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this hypothesis was given by a median joining network analysis, which indicated that 
these four badger sequences were at least  2.5-times (gray fox amdovirus 3.8-times) more 
distant from their closest neighbor compared to ‘regular’ AMDV genotypes (Saarma, 2014 
unpublished observations). However, more sequence data are needed to establish that the 
badger strain is sufficiently distinct to warrant recognition as a new species. Work 
involving next-generation sequencing is underway. In addition to the badgers in Estonia, it 
is possible that new amdoparvoviruses may also be found in indigenous mustelids of 
Finland. 
For species other than mink and ferret, it is often the case that viruses (AMDV or 
related) causing the infection and antibody response are poorly documented and 
information on their evolutionary relationships is limited. Ferrets seem to carry viruses 
that are divergent from mink strains both biologically (Porter et al., 1982) and genetically 
(<90% nt identity to mink AMDVs, partial VP2) (Saifuddin and Fox, 1996; Murakami et 
al., 2001). Phylogenetic analysis resolved strains from ferrets in a distinct cluster 
(Murakami et al., 2001). In the wild, in addition to mink, similar AMDV strains (cross-
species transmission) are carried by polecats, pine martens, and badgers (study IV), as 
well as by raccoons (Oie et al., 1996). Additionally, divergent strains seem to exist in 
other mustelids and carnivores. Nituch et al. (2015) showed that Canadian striped skunks 
carry strains that form a separate lineage from feral and wild mink strains having 82% to 
91% nt identities (partial NS1) to mink strains. European mink and Eurasian otters may 
also carry AMDV strains that diverge from mink strains (Mañas et al., 2001). Notably, 
new amdoparvoviruses have recently been found in raccoon dogs and foxes (Li et al., 
2011; Shao et al., 2014; Bodewes et al., 2014a). Amdoparvoviruses in raccoon dogs and 
arctic foxes show 82% (Shao et al., 2014) and gray foxes 74% nt identities (complete 
NS1) to mink strains (Li et al., 2011). No official species or strain-demarcation criteria 
currently exist for amdoparvoviruses (Tijssen et al., 2011). Generally, different species 
belonging to genera in the Parvovirinae subfamily are <95% related within the NS1 DNA 
sequence, are antigenically distinct, and are found predominantly in a single natural host 
species (Tijssen et al., 2011). A recent proposal to update the taxonomy of Parvoviridae 
requires the same species to show over 85% identity in the aa sequence of NS1 (Cotmore 
et al., 2014). Aleutian mink disease virus strains share over 87% nt and 82% aa identities 
within the NS1 gene (Li et al., 2011), thus the proposed criterion seems more suitable for 
AMDV. 
6.2.4. No clustering according to pathogenicity, year, or location (I, IV) 
Similar to the findings of previous studies (Schuierer et al., 1997; Olofsson et al., 1999; 
Nituch et al., 2012; Leimann et al., 2015), we found no clusters that associated with 
pathogenicity, year of isolation, or geographical origin. Known pathogenic strains were 
identified in almost all clusters and they appear to have independently evolved from less 
pathogenic clusters. Thus, a molecular basis to explain the AMDV outbreaks that occurred 
in 2004 and 2005 at farms D, E, and F could not be found (I). Furthermore, no inferences 
can be made on the pathogenicity of the strains circulating in the wild (IV). Such data 
would be very important to the conservation of endangered species. The determinants of 
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AMDV pathogenicity (see Chapter 2.3.1. for references) are apparently complex and, in 
addition to host factors, interaction of several genes (Schuierer et al., 1997; McCrackin 
Stevenson et al., 2001) and other features (e.g., caspase cleavage and apoptosis) (Best et 
al., 2002; Cheng et al., 2010) are probably involved. In general, most field strains 
circulating at farms appear to be of low or moderate pathogenicity (Gorham et al., 1976; 
Hadlow et al., 1983; Porter, 1986). The limited clinicopathologic and epidemiologic data 
also suggest that several strains of variable pathogenicity are circulating within Finnish 
farms (Knuuttila, 2007). While certain studies show some degree of geographical 
clustering across countries or regions (Christensen et al., 2011; Nituch et al., 2012; Sang et 
al., 2012), others do not (study I and IV, Leimann et al., 2015).The lack of geographical 
clustering of Finnish strains may be due to largely unregulated movement of animals in 
the global mink trade, and the rather short duration of domestic eradication program. In 
Denmark, where the long-standing eradication has been quite successful in controlling 
AMDV, geographic clustering was more apparent (Christensen et al., 2011).  
6.2.5. Host range in Finland (IV) 
Anti-AMDV antibodies or viral DNA was detected in three of the eight species of free-
ranging mustelids in Finland. Prevalence was highest in the feral American mink, 
followed by European badgers, and polecats. Samples from pine martens, Eurasian otters, 
least weasels, wolverine, and stoat were negative. The actual sample size (308) was only 
20% smaller than the ideal sample size (385) suggested to provide an accurate estimate of 
prevalence in all mustelid species. Thus, the overall prevalence (13%, 95% CI 9–17) can 
be assumed to be quite reliable. However, it should be stressed that sample sizes for 
detecting disease or to estimate prevalence were too small for most species. As in the 
calculation of the sample size to assess prevalence, the estimated true prevalence was 
assumed to be 50% (which is often the case in feral mink) thus resulting in the largest 
required sample size. However, if an estimate of 5% to 40% (usually found in other 
species) would have been made, the required sample size would have been smaller, from 
73 to 369. Thus, at least for pine martens, the sample size for estimating prevalence can be 
considered sufficient. Additionally, the 95% CI seemed to be acceptable for feral mink. 
Thus, although infection was identified in three species, it is possible that it is present in 
the other four species (maybe excluding the pine marten) and prevalence is higher or 
lower than reported here. More samples are required to resolve this issue. Especially, the 
infection status of the wolverine and polecat should be clarified as the wolverine is 
critically endangered and the polecat is considered vulnerable (Liukko et al., 2010). 
Aleutian mink disease virus is resistant to many environmental conditions (reviewed by 
Cho, 1976; Hussain et al., 2014), but it is possible that the storage conditions (at RT, 4 °C, 
and -20 °C) and time (up to several months) of the filter paper blood samples and the 
autolysis of some of the carcasses might have resulted in degradation of antibodies and/or 
viral DNA, thereby yielding false-negatives. Generally, regardless of some time and 
temperature dependent loss, filter paper sampling seems to be a robust and reliable method 
for serological and PCR assay (Prado et al., 2005; Liang et al., 2014; Dauner et al., 2015). 
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Aleutian mink disease virus infection, as far as is known, has not previously been 
reported in European badgers. In feral mink, similar or lower prevalences have been 
reported elsewhere in Europe (Mañas et al., 2001; Yamaguchi and Macdonald, 2001; 
Fournier-Chambrillon et al., 2004; Jensen et al., 2012). Compared to the farmed mink with 
a prevalence of 15% in 2014 (M. Eerola [Fin Furlab], personal communication 21.5.2015), 
the feral mink and badgers had a considerably higher prevalence. Aleutian mink disease 
virus-positive polecats, stoats, a European otter, and a pine marten have also been found 
previously (Mañas et al., 2001; Fournier-Chambrillon et al., 2004; Farid, 2013). Natural 
infections have not been studied in least weasels and wolverines. Experimentally, two 
wolverines have been inoculated with AMDV, but failed to develop antibodies or lesions 
(Kenyon et al., 1978). We detected a positive sample in a single Finnish polecat, whereas 
samples from Finnish otters, pine martens, least weasels, wolverine, and stoat were 
negative. However, we were able to obtain sequences from three Estonian pine martens. 
We also tested additional samples with negative results from captive mustelids: one 
sample from a wolverine (submitted by Helsinki Zoo [Korkeasaari] for necropsy in the 
Faculty of Veterinary Medicine) and 43 samples from least weasels (organs submitted by 
the University of Jyväskylä) (Knuuttila, 2014 unpublished observations). Blood samples 
from 23 Estonian raccoon dogs were analyzed due to their potential role in the 
transmission of AMDV, but these were also negative (Knuuttila, 2014 unpublished results, 
Leimann et al., 2015). These data were, however, excluded from study IV as the aim was 
to study Finnish free-ranging mustelids.  
Although many species may become infected, disease in free-ranging mustelids has 
only been detected in mink (Cho and Greenfield, 1978; Mañas et al., 2001; Persson et al., 
2015) and striped skunk (LaDouceur et al., 2014). Additionally, 
hypergammaglobulinemia, which is related to development of lesions in mink (Larsen and 
Porter, 1975; Henson et al., 1976; reviewed by Porter, 1986; reviewed by Jackson et al., 
1996a), has been detected in a few European mink, stone martens, and one pine marten 
(Fournier-Chambrillon et al., 2004). The wild AMDV strains found in Finnish mink and 
badgers are probably not very pathogenic; although the prevalence was quite high in these 
species their population sizes are viable. However, pathogenicity of the putative new 
amdoparvovirus in Estonian badgers is puzzling. One of the recently discovered 
amdoparvoviruses was linked to diarrhea epidemics among farmed arctic fox and raccoon 
dog cubs (Shao et al., 2014). Less information is available on the other two new 
amdoparvoviruses in gray and red foxes (Li et al., 2011; Bodewes et al., 2014a) and their 
ability to cause disease. Thus, more data are needed on the pathogenesis and pathology of 
AMDV and other amdoparvoviruses in many of their host species, especially in those that 
are endangered. 
Our results infer that some PCR methods may be less sensitive in detecting (and 
therefore less suitable for screening) AMDV infection in wild/feral animals. Many of the 
screening studies have used primers described either by Olofsson et al. (1999) (partial 
NS1) or Oie at al. (1996) (partial VP2). We noticed that these primers failed to identify all 
AMDV strains, as many seropositive samples were DNA negative with these methods. A 
similar tendency was noted in the confirmation testing of positive individuals in the 
ELISA test, which was initially performed with these primers (Aaltonen and Sironen 
unpublished observations). Three of seven positives were missed by the NS1 protocol and 
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seven of 18 with the VP2 protocol (study IV). As a result of this, a new pan-amdo qPCR 
test was developed based on the gray fox amdovirus sequence. Notably, the Estonian 
strains in study IV originated from the same samples used by Leimann et al. (2015). In 
this study, AMDV DNA was only identified in mink samples, whereas in study IV we also 
identified it in badgers, pine martens, and a polecat. At least in mink, the viremia may be 
transient and intermittent (Jensen et al., 2014), but in the case of highly pathogenic strains 
it seems to persist for at least 60 days (Oie et al., 1996). Regardless of that, we were able 
to detect AMDV DNA in the blood samples of all seropositive animals except the badger. 
In this species, none of the animals were determined to be positive by both ELISA and 
qPCR (5 ELISA-positive, but PCR-negative; 2 ELISA-negative, but PCR-positive). Given 
that the spleens of seropositive badgers were also negative for AMDV DNA, it is possible 
that they are able to clear the virus. Due to these findings we recommend using both 
serologic assays and PCR to screen for AMDV in free-ranging mustelids.  
This was the first time that the AMDV VP2 ELISA was used for detecting anti-AMDV 
antibodies in species other than mink. Based on these results, it also seems suitable for this 
purpose. Except for the badgers, the qPCR and ELISA tests had only two discordant 
results; mink that were ELISA-negative but PCR-positive. This might be due to a recent 
infection with no or an undetectable level of antibodies. This study provided new 
information on the host range of AMDV in Finland and new detection methods were 
established that can detect a wide diversity of strains. These advancements will facilitate 
further research in control, conservation efforts, and biosecurity at farms and international 
borders. 
6.2.6. AMDV has wide geographical distribution (IV) 
Aleutian mink disease virus infection was distributed throughout most (10/17) of the 
sampled regions. The prevalence was quite high (>20%) in certain regions, but sample 
sizes were too small or the sampling was often biased towards infected or AMDV-free 
species (e.g., Lapland and pine marten) to reliably assess the regional prevalences and the 
95% CIs were quite wide except for Kanta-Häme. However, the target sample size (5–60) 
necessary to detect disease was reached in 11 of 17 regions. Differences in prevalence 
between the regions were not statistically significant. Pooling regions into larger areas 
(e.g., the former provinces of Oulu, Lappi, Southern, Western, and Eastern Finland) and 
obtaining more observations (20–165/province) failed to reveal any significant differences 
in prevalence (Knuuttila, 2014 unpublished observations). Initially, we assumed that the 
prevalence would be higher in the western parts of Finland due to the long history of mink 
farming there. Interestingly, the prevalence was also quite high in eastern Finland. This 
might be due to suitable habitat for mink, intentional release of mink (Kauhala, 1996) and 
history of fur farming in Russia near the Finnish border. Further studies are necessary to 
clarify the prevalence of AMDV in each species across Finland and to determine whether 
any spatial differences exist. 
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6.2.7. Feral American mink and badgers have a higher odds for infection (IV) 
While mink (OR 335), badger (OR 74) and the 2006–2009 sampling period (OR 5) were 
associated with AMDV infection in free-ranging mustelids, age, sex, region, or the 
presence of mink farm in the area (at the municipal or regional level) were not. We 
acknowledge that all potential risk factors were not studied here due to a limited number 
of observations. Additionally, different species were not studied separately, but they 
probably carry dissimilar risk factors due to differences in their ecology. 
Significantly higher prevalence in feral American mink than in other species (Fournier-
Chambrillon et al., 2004) and no difference between the sexes (Fournier-Chambrillon et 
al., 2004; Farid, 2013) has been reported by others. Similarly, an increased risk of 
infection has been reported in adult feral mink (Yamaguchi and Macdonald, 2001; Persson 
et al., 2015) and in adult and subadult free-ranging mustelids (Fournier-Chambrillon et al., 
2004). In our study, the prevalence was higher in juveniles than in adults but the 
difference was not significant. The age was estimated subjectively by the sample collector, 
and this may have influenced results. Age could have been better assessed through an 
analysis of the cementum annuli in the teeth (Lyons et al., 2012). However, this would 
have led to reduced sample numbers or limited the number of teeth submitted for analysis 
due to a more laborious sampling protocol. Temporal fluctuations in AMDV prevalence in 
the wild has not been reported before. We tested whether the differences between years 
could have been caused by sampling infected regions or species during the earlier (2006–
2009) and AMDV-free regions or species during the later (2010–2014) period. We 
observed that the higher prevalence from 2006–2009 was not due to a sampling bias 
(Knuuttila, 2014 unpublished observations). Whether this difference is incidental or due to 
other factors such as changes in population density or environmental conditions warrants 
further research. Furthermore, fluctuations in the population density of important prey 
animals such as voles, may also play a role and during high-density periods mustelids may 
breed intensively and spread the virus more effectively. The 2006–2009 sampling period 
coincided with a high-density phase of the vole population cycle (Korpela et al., 2013), 
whereas between 2010–2014 the numbers were more moderate. In Finnish farmed mink 
the prevalence was lower (3–11%) 2006–2009 and higher (11–15%) 2010–2014, contrary 
to what was found in free-ranging mustelids.  
6.2.8. Transmission of AMDV in the wild (IV) 
Although most of the strains in the wild and at farms are closely related and share 
common ancestors, results of the statistical and phylogenetic analyses (IV) suggest that 
mink farms do not represent a major source of AMDV infection in free-ranging 
populations of Finland, at least at the municipal or regional level. Infected animals were 
also detected in regions where no mink farms currently operate, such as Päijät-Häme, 
Etelä-Savo, and South Karelia (Figure 5). The AMDV prevalence in free-ranging 
mustelids was actually significantly lower in those regions that had mink farms (10.2%), 
in contrast to those regions that had no farms (21.9%). If the farms were providing a 
reservoir of infection for free-ranging mustelids, a greater prevalence would have been 
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expected in those regions with mink farms. The phylogeny also supported the notion of a 
relatively trivial role played by mink farms in AMDV transmission (Figure 6), where 
clusters were composed of strains from different regions. Furthermore, mixing of strains 
of farm and wild origin was not evident (except for a single case in Group IV) and the 
strains from farmed and feral mink appeared to form separate clusters. Conversely, these 
data infer that rather than farms, feral mink and possibly badgers seem to be more 
important in the transmission of AMDV in the wild. Those species that share territory or 
come into contact with feral mink may be at risk. Infected escapees from farms and 
infections acquired at farms and transmitted by wild/feral animals to farms may still play a 
local role, especially if biosecurity measures at farms are inadequate. A more detailed 
epidemiologic study taking into account the number of local farms, their size, infection 
status, contacts, and biosecurity protocols would reveal more data on the transmission of 
the virus in the vicinity of mink farms. 
Until recently, data on the sylvatic cycle and transmission between farms and the wild 
have been scarce. Some studies suggest that the transmission cycles are separate (Leimann 
et al., 2015) and others infer an intersection (Oie et al., 1996; Nituch et al., 2011; Nituch et 
al., 2012; Nituch et al., 2015). This suggests that the situation varies between countries, 
and might reflect for instance the differences in the farming practices, density and number 
of farms, geography, size of the studied area, and populations of mustelid species and their 
ecology. As seen in study IV, strains isolated from wild and feral mink, although closely 
related to strains from farmed mink, tend to form separate clusters (Jensen et al., 2012; 
Nituch et al., 2012; Leimann et al., 2015). Also, Leimann et al. (2015) showed that 
although the strains in feral mink originate from the global mink trade, the current sylvatic 
and domestic transmission cycles in Estonian mink are separate. A Canadian study 
indicated that farms may act as a source of viral infections in the wild (Nituch et al., 
2011). Interestingly, wild vicinal raccoons have been implicated in AD outbreaks in farms 
while transmission from raccoon-to-raccoon is unlikely (Oie et al., 1996). In the wild, 
striped skunks may transmit the virus to wild mink (Nituch et al., 2015). Furthermore, in 
Canada where mink is native, the virus is carried between free-ranging domestic, wild, and 
hybrid mink and between mink farms and wild mink (Nituch et al., 2012). Experimental 
studies further suggest that raccoon dogs, cats, dogs, ferrets, and mice may serve as 
AMDV reservoirs and may be involved in AMDV circulation in mink farms 
(Alexandersen et al., 1985b). 
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7. Conclusions 
? A new recombinant AMDV VP2 antigen was developed. It spontaneously formed 
VLPs and was antigenic in several serologic methods. It can be produced quickly 
in large quantities and after simple purification works both in CIEP and ELISA. 
? Based on this antigen, a new and accurate ELISA test for the serodiagnosis of 
AMDV infection in mink was developed, automated, and validated. This test has 
several appealing features including low cost, rapid processing of large batches, 
reduced labor requirement, and digital data management. 
? A new, rapid, and simple blood sampling method, filter-paper ‘blood comb’, was 
developed for the ELISA test. 
? The virus has been introduced at least three times to Finnish farms, but the exact 
origin of the Finnish strains remains to be clarified. 
? Finnish AMDV strains showed high variability and strains from several 
genogroups are circulating in captive and wild populations. 
? The phylogeny showed no clear clustering based on the year of isolation, 
geographical origin, host species, or pathogenicity.  
? A new host species of AMDV, the European badger, was identified. 
? In addition to the badger, AMDV infection was detected in the feral American 
mink and polecat in Finland. For the first time, AMDV sequence data was obtained 
from the polecat, pine marten, and badger. 
? AMDV is widely distributed in the wild throughout Finland. 
? Although Finnish free-ranging mustelids carry strains similar to mink (an 
indication of cross-species transmission), divergent strains representing potential 
novel amdoparvoviruses such as the one identified in Estonian badgers, may also 
be present.  
? Factors associated with higher odds of AMDV infection in free-ranging mustelids 
were the species (feral American mink and badger) and sampling period (2006–
2009). 
? Domestic and sylvatic transmission cycles seem to be mainly separate, at least at 
the broad scale, and the major source of virus in the wild is feral mink and possibly 
badger. Mink farms, however, may have a greater impact at the local scale. 
? These studies introduced new diagnostic tools that can be utilized in AMDV 
monitoring and eradication programs, as well as further research. Additional 
sequence data for investigating the molecular epidemiology of AMDV were 
generated. Details of AMDV epidemiology and phylogenetics in Finnish farmed 
mink and free-ranging mustelids were clarified, providing new information on 
AMDV strain diversity, host species, transmission, and factors associated with 
infection. These results may have an impact on best practice of biosecurity 
protocols, investigation of outbreaks at farms, and conservation of endangered 
mustelid species. 
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Appendix 1 
Aleutian mink disease virus strains studied in this thesis 
Strain Species Country, 
region 
Isolation 
year 
Pathogenicity Reference GenBank 
acc. no. 
FIN05/B4a Farmed 
American 
mink 
Finland, 
Ostrobothnia 
2005 NDb I and IV EU908029 
and 
KM374785 
FIN05/B5 -‘’- -‘’- -‘’- -‘’- I EU908030 
FIN05/B6 -‘’- -‘’- -‘’- -‘’- -‘’- EU908031 
FIN05/C7 -‘’- -‘’- -‘’- -‘’- I and IV EU908032 
and 
KM374782 
FIN05/C8 -‘’- -‘’- -‘’- -‘’- I and II EU908033 
and 
GQ336866 
FIN05/C9 -‘’- -‘’- -‘’- -‘’- -‘’- EU908034 
FIN05/D10 -‘’- Finland, 
North 
Ostrobothnia 
-‘’- high I and IV EU908035 
and 
KM374783 
FIN05/D11 -‘’- -‘’- -‘’- -‘’- I EU908036 
FIN05/D12 -‘’- -‘’- -‘’- -‘’- I and IV EU908037 
and 
KM374784 
FIN05/E13 -‘’- Finland, 
Ostrobothnia 
-‘’- ND I EU908038 
FIN05/E14 -‘’- -‘’- -‘’- -‘’- -‘’- EU908039 
FIN05/E15 -‘’- -‘’- -‘’- -‘’- -‘’- EU908040 
FIN05/F16 -‘’- -‘’- -‘’- High -‘’- EU908041 
FIN05/F17 -‘’- -‘’- -‘’- High I and IV EU908042 
and 
KM374812 
A1 -‘’- Sweden, 
Blekinge 
1995 ND (Olofsson et 
al., 1999) 
AF107626 
A2 -‘’- -‘’- -‘’- -‘’- -‘’- AF107627 
B1 -‘’- -‘’- -‘’- -‘’- -‘’- AF107628 
B2 -‘’- -‘’- -‘’- -‘’- -‘’- AF107629 
B3 -‘’- -‘’- -‘’- -‘’- -‘’- AF107630 
C1 -‘’- -‘’- -‘’- -‘’- -‘’- AF107631 
D1 -‘’- -‘’- -‘’- -‘’- -‘’- AF107632 
D2 -‘’- -‘’- -‘’- -‘’- -‘’- AF107633 
E1 -‘’- -‘’- -‘’- -‘’- -‘’- AF107634 
E2 -‘’- -‘’- -‘’- -‘’- -‘’- AF107635 
F1 -‘’- -‘’- -‘’- -‘’- -‘’- AF107636 
F2 -‘’- -‘’- -‘’- -‘’- -‘’- AF107637 
F3 -‘’- -‘’- -‘’- -‘’- -‘’- AF107638 
G1 -‘’- -‘’- -‘’- -‘’- -‘’- AF107639 
H1 -‘’- -‘’- -‘’- -‘’- -‘’- AF107640 
H2 -‘’- -‘’- -‘’- -‘’- -‘’- AF107641 
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Strain Species Country, 
region 
Isolation 
year 
Pathogenicity Reference GenBank 
acc. no. 
H3 -‘’- -‘’- -‘’- -‘’- -‘’- AF107642 
I1 -‘’- -‘’- -‘’- -‘’- -‘’- AF107643 
I2 -‘’- -‘’- -‘’- -‘’- -‘’- AF107644 
J1 -‘’- Sweden, 
Halland 
-‘’- -‘’- -‘’- AF107645 
K1 -‘’- Sweden, 
Skaraborg 
-‘’- -‘’- -‘’- AF107646 
K2 -‘’- -‘’- -‘’- -‘’- -‘’- AF107647 
L1 -‘’- -‘’- -‘’- -‘’- -‘’- AF107648 
L2 -‘’- -‘’- -‘’- -‘’- -‘’- AF107649 
M1 -‘’- -‘’- -‘’- -‘’- -‘’- AF107650 
M2 -‘’- -‘’- -‘’- -‘’- -‘’- AF107651 
N1 -‘’- Sweden, 
Skåne 
1997 -‘’- -‘’- AF107652 
N2 -‘’- -‘’- -‘’- -‘’- -‘’- AF107653 
N3 -‘’- -‘’- -‘’- -‘’- -‘’- AF107654 
O1 -‘’- Sweden, 
Älvsborg 
-‘’- -‘’- -‘’- AF107655 
O2 -‘’- -‘’- -‘’- -‘’- -‘’- AF107656 
P1 -‘’- Finland, 
Ostrobothnia 
-‘’- -‘’- -‘’- AF107657 
Q1 -‘’- -‘’- 1996 -‘’- -‘’- AF107658 
R1 -‘’- -‘’- 1997 -‘’- -‘’- AF107659 
R2 -‘’- -‘’- -‘’- -‘’- -‘’- AF107660 
Nevi18_NO06c Feral 
American 
mink  
Finland, 
North 
Ostrobothnia 
2006 ND IV KM374772 
Nevi23_NO07 -‘’- -‘’- 2007 -‘’- -‘’- KM374790 
Nevi45_NO08 -‘’- -‘’- 2008 -‘’- -‘’- KM374813 
Nevi47_SK08 -‘’- Finland, 
South Karelia 
-‘’- -‘’- -‘’- KM374794 
Mupu87_EE08 Polecat  Estonia -‘’- -‘’- IV and 
(Leimann et 
al., 2015) 
KM374800 
Mama106_EE08 Pine 
marten  
-‘’- -‘’- -‘’- -‘’- KM374780 
Meme125_EE07 Badger -‘’- 2007 -‘’- -‘’- KM374801 
Meme132_EE08 -‘’- -‘’- 2008 -‘’- -‘’- KM374803 
Meme133_EE08 -‘’- -‘’- -‘’- -‘’- -‘’- KM374804 
Meme134_EE08 -‘’- -‘’- -‘’- -‘’- -‘’- KM374805 
Mama147_EE08 Pine 
marten  
-‘’- -‘’- -‘’- -‘’- KM374807 
Mama161_EE07 -‘’- -‘’- 2007 -‘’- -‘’- KM374806 
Nevi229_EE09 Feral 
American 
mink  
-‘’- 2009 -‘’- -‘’- KM374808 
Nevi232_EE08 -‘’- -‘’- 2008 -‘’- -‘’- KM374809 
Nevi238_PS09 -‘’- Finland, 2009 -‘’- IV KM374776 
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Strain Species Country, 
region 
Isolation 
year 
Pathogenicity Reference GenBank 
acc. no. 
Pohjois-Savo 
Nevi249_ES08 -‘’- Finland, 
Etelä-Savo 
2008 -‘’- -‘’- KM374810 
Nevi251_KH08 -‘’- Finland, 
Kanta-Häme 
-‘’- -‘’- -‘’- KM374797 
Nevi266_KH09 -‘’- -‘’- 2009 -‘’- -‘’- KM374811 
Nevi267_NK09 -‘’- Finland, 
North Karelia 
-‘’- -‘’- -‘’- KM374792 
Nevi275_SK09 -‘’- Finland, 
South Karelia 
-‘’- -‘’- -‘’- KM374793 
Nevi326_KH10 -‘’- Finland, 
Kanta-Häme 
2010 -‘’- -‘’- KM374774 
Nevi358_CF08 -‘’- Finland, 
Central 
Finland 
2008 -‘’- -‘’- KM374778 
Meme360_CF08 Badger  -‘’- -‘’- -‘’- -‘’- KM374802 
Mupu363_CF08 Polecat  -‘’- -‘’- -‘’- -‘’- KM374791 
Nevi435_SO13 Feral 
American 
mink 
Finland, 
South 
Ostrobothnia 
2013 -‘’- -‘’- KM374773 
Meme442_SO13 Badger -‘’- -‘’- -‘’- -‘’- KM374796 
Nevi454_SK13 Feral 
American 
mink 
Finland, 
South Karelia 
-‘’- -‘’- -‘’- KM374795 
Nevi456_U13 -‘’- Finland, 
Uusimaa 
-‘’- -‘’- -‘’- KM374798 
Nevi458_U13 -‘’- -‘’- -‘’- -‘’- -‘’- KM374799 
Nevi479_SO13 -‘’- Finland, 
South 
Ostrobothnia 
-‘’- -‘’- -‘’- KM374781 
FIN12/G18 -‘’- Finland, 
Ostrobothnia 
2012 ND -‘’- KM374777 
FIN13/H19 -‘’- -‘’- 2013 -‘’- -‘’- KM374786 
FIN13/I20 -‘’- -‘’- -‘’- -‘’- -‘’- KM374788 
FIN13/J21 -‘’- -‘’- -‘’- -‘’- -‘’- KM374789 
FIN13/K22 -‘’-  -‘’- -‘’- -‘’- -‘’- KM374779 
FIN13/K23 -‘’- -‘’- -‘’- -‘’- -‘’- KM374775 
FIN14/L24 -‘’- -‘’- 2014 -‘’- -‘’- KM374787 
AMDV-LN1 -‘’- China 2009 High (Li et al., 
2012)  
GU108231 
AMDV-LN2  -‘’- China -‘’- High -‘’- GU108232 
AMDV-G -‘’- USA Late 
1970s 
None (Bloom et al., 
1980; Bloom 
et al., 1990; 
Huang et al., 
2012)  
M20036 
and 
JN040434 
AMDV-Utah1 -‘’- USA, Utah 1963 High (Bloom et al., 
1988; 
Gottschalck 
et al., 1994)  
X77083 and 
Z18276 
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Strain Species Country, 
region 
Isolation 
year 
Pathogenicity Reference GenBank 
acc. no. 
AMDV-SL3 -‘’- Germany Early 
1980s 
Moderate (Haas et al., 
1990; 
Schuierer et 
al., 1997)  
X97629 
AMDV-K -‘’- Denmark 1982 High (Gottschalck 
et al., 1994) 
X77084 
AMDV-United -‘’- USA ND High (Gottschalck 
et al., 1994) 
X77085 
       
a Abbreviation of the country, succeeded by farm identification and animal number.  
b No data. 
c Abbreviation of the Latin name, succeeded by number identification, abbreviation of the region or country, and year of 
isolation. Nevi, Neovison vison, American mink; Mupu, Mustela putorius, polecat; Mama, Martes martes, pine marten; 
Meme, Meles meles, badger. 
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